<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1089374</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Phospholipase C: underrated players in microbial infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Vinayak</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2263163"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rai</surname>
<given-names>Rupal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2264326"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mathew</surname>
<given-names>Bijina J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2182840"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chourasia</surname>
<given-names>Rashmi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Anirudh K.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/681224"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Awanish</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/359932"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chaurasiya</surname>
<given-names>Shivendra K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/931463"/>
</contrib>
</contrib-group>    <aff id="aff1">
<sup>1</sup>
<institution>Molecular Signalling Lab, Department of Biological Science and Engineering, Maulana Azad National Institute of Technology</institution>, <addr-line>Bhopal, Madhya Pradesh</addr-line>, <country>India</country>
</aff>    <aff id="aff2">
<sup>2</sup>
<institution>Department of Chemistry, IES University, Bhopal</institution>, <addr-line>Madhya Pradesh</addr-line>, <country>India</country>
</aff>    <aff id="aff3">
<sup>3</sup>
<institution>School of Sciences, SAM Global University</institution>, <addr-line>Raisen, Madhya Pradesh</addr-line>, <country>India</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Biotechnology, National Institute of Technology</institution>, <addr-line>Raipur, Chhattisgarh</addr-line>, <country>India</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Seung-Hak Cho, Korea National Institute of Health, Republic of Korea</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Kurt Schesser, University of Miami, United States; Daniel Alford Powell, University of Arizona, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shivendra K. Chaurasiya, <email xlink:href="mailto:shivendrachaurasiya@gmail.com">shivendrachaurasiya@gmail.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Molecular Bacterial Pathogenesis, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>04</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1089374</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Singh, Rai, Mathew, Chourasia, Singh, Kumar and Chaurasiya</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Singh, Rai, Mathew, Chourasia, Singh, Kumar and Chaurasiya</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>During bacterial infections, one or more virulence factors are required to support the survival, growth, and colonization of the pathogen within the host, leading to the symptomatic characteristic of the disease. The outcome of bacterial infections is determined by several factors from both host as well as pathogen origin. Proteins and enzymes involved in cellular signaling are important players in determining the outcome of host&#x2013;pathogen interactions. phospholipase C (PLCs) participate in cellular signaling and regulation by virtue of their ability to hydrolyze membrane phospholipids into di-acyl-glycerol (DAG) and inositol triphosphate (IP3), which further causes the activation of other signaling pathways involved in various processes, including immune response. A total of 13 PLC isoforms are known so far, differing in their structure, regulation, and tissue-specific distribution. Different PLC isoforms have been implicated in various diseases, including cancer and infectious diseases; however, their roles in infectious diseases are not clearly understood. Many studies have suggested the prominent roles of both host and pathogen-derived PLCs during infections. PLCs have also been shown to contribute towards disease pathogenesis and the onset of disease symptoms. In this review, we have discussed the contribution of PLCs as a determinant of the outcome of host-pathogen interaction and pathogenesis during bacterial infections of human importance.</p>
</abstract>
<kwd-group>
<kwd>bacterial infections</kwd>
<kwd>cell signaling</kwd>
<kwd>phospholipase C</kwd>
<kwd>tuberculosis</kwd>
<kwd>phospholipids (PL)</kwd>
<kwd>
<italic>Listeria monocytogenes</italic>
</kwd>
<kwd>
<italic>Helicobabacter pylori</italic>
</kwd>
<kwd>
<italic>Clostridium perfringens</italic>
</kwd>
</kwd-group>    <contract-sponsor id="cn001">Science and Engineering Research Board<named-content content-type="fundref-id">10.13039/501100001843</named-content>
</contract-sponsor>    <contract-sponsor id="cn002">Maulana Azad National Institute of Technology<named-content content-type="fundref-id">10.13039/100019352</named-content>
</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="185"/>
<page-count count="17"/>
<word-count count="9008"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>In all living organisms, phospholipids are present as a major component of all cellular membranes, along with cholesterol and glycolipids. The phospholipid membrane separates the extracellular and intracellular environments and serves as a scaffold for the membrane-associated proteins. Membrane phospholipids and their hydrolytic products play a significant role in cellular signaling (<xref ref-type="bibr" rid="B118">Pelech and Vance, 1989</xref>; <xref ref-type="bibr" rid="B36">Exton, 1990</xref>; <xref ref-type="bibr" rid="B82">Kumari et al., 2018</xref>). Phospholipids have structural variation in the hydrophilic head group [such as phosphatidylinositol (PI) or phosphatidylcholine (PC)] and are attached to fatty acid chains of varying length and saturation. Variability in the structure of phospholipids enables them to play different functions in the cell membrane and cell signaling (<xref ref-type="bibr" rid="B160">Verkleij et&#xa0;al., 1973</xref>).</p>
<p>Phospholipases (PLs) are the ubiquitous group of enzymes that catalyze the hydrolysis of phospholipids by cleaving the ester bond. After hydrolysis, secondary messengers are generated, which are further involved in cell signaling, membrane trafficking, cell proliferation, etc (<xref ref-type="bibr" rid="B13">Barrett-Bee et&#xa0;al., 1985</xref>; <xref ref-type="bibr" rid="B27">Cox et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B130">Sato et&#xa0;al., 2016</xref>). PLs have different sites of cleavage on phospholipid molecules, therefore the PLs are classified as PLA, PLB, PLC, and PLD (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). The PLA are acyl hydrolases and are further classified into two subtypes: PLA1 and PLA2. PLA1 cleaves the acyl ester bond at the sn-1 position to produce free fatty acids and lysophospholipids, whereas PLA2 cleaves at the sn-2 position to produce arachidonic acid and lysophosphatidic acid (<xref ref-type="bibr" rid="B132">Scandella and Kornberg, 1971</xref>; <xref ref-type="bibr" rid="B159">Vasquez et&#xa0;al., 2018</xref>). PLB can hydrolyze both the acyl groups, and its lysophospholipase activity is responsible for cleaving the bond between the fatty acid and the lysophospholipid (<xref ref-type="bibr" rid="B85">Leidich et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B176">Wilton, 2008</xref>). PLCs cleave the phosphodiester bond between the glycerol backbone and the phosphate group to produce diacylglycerol (DAG) and a phosphate-containing head group (<xref ref-type="bibr" rid="B147">Suh et al., 2008</xref>). PLD catalyzes the removal of the phospholipid head group on the polar side to produce phosphatidic acid and alcohol. Therefore, PLC and PLD are phosphodiesterases (<xref ref-type="bibr" rid="B147">Suh et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B1">Abdulnour et&#xa0;al., 2018</xref>). In this review, we mainly focus on the role of PLCs in bacterial infections.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>phospholipase cleavage sites on phospholipid substrates: phospholipase A1 (PLA1) and phospholipase A2 (PLA2) cleave the ester bond at the sn-1 and sn-2 positions of phospholipids, respectively. Phospholipase B (PLB) can also hydrolyze at both the sn-1 and sn-2 positions. phospholipase C (PLC) hydrolyzes the phosphodiester bond between the glycerol backbone and the phosphate group. Phospholipase D (PLD) hydrolyzes the phosphodiester bond on the polar side to remove the head group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g001.tif"/>
</fig>
<p>On the basis of the type of organisms, the PLCs are categorized as bacterial PLCs and mammalian PLCs. In 1941, Macfarlane and Knight were the first to demonstrate that the &#x3b1;-toxin of <italic>Clostridium perfringens</italic> was a PLC. Since then, PLCs have been recognized as potential virulence factors required during the pathogenesis of several bacteria (<xref ref-type="bibr" rid="B156">Titball, 1993</xref>; <xref ref-type="bibr" rid="B143">Songer, 1997</xref>; <xref ref-type="bibr" rid="B82">Kumari et al., 2018</xref>). While PLCs are produced by several pathogenic and nonpathogenic bacteria, the focus of this review is on the PLCs of some of the most important human pathogens (<xref ref-type="bibr" rid="B156">Titball, 1993</xref>; <xref ref-type="bibr" rid="B143">Songer, 1997</xref>). PLCs can be further grouped on the basis of the preferred substrates they utilize (<xref ref-type="bibr" rid="B156">Titball, 1993</xref>). Accordingly, PLCs can be PI-PLCs, PC-PLCs, and nonspecific PLCs (<xref ref-type="bibr" rid="B4">Aloulou et&#xa0;al., 2018</xref>). PI-PLCs have been detected in a wide variety of organisms, including bacteria, plants, and animals. Prokaryotic PI-PLCs consist of a single domain of 30&#x2013;35 kDa and act as a virulence factor in several pathogenic bacteria. Eukaryotic PI-PLCs are large (80&#x2013;150 kDa) and consist of several distinct domains that play predominant roles in signal transduction and generate inositol 1,4,5-triphosphate (IP3) and DAG by the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). Thus, PLCs regulate the concentrations of PIP2, IP3, and DAG within the cell, which play critical roles in cellular signaling (<xref ref-type="bibr" rid="B58">Heinz et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B71">Kadamur and Ross, 2013</xref>). For optimal catalytic activity, bacterial and mammalian PLCs require calcium ions (Ca<sup>2+</sup>) and zinc ions (Zn<sup>2+</sup>), respectively, as cofactors (<xref ref-type="bibr" rid="B58">Heinz et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B7">Aurass et al., 2013</xref>).</p>
</sec>
<sec id="s2">
<title>Mechanism of PLC activation</title>
<p>PLC in association with Ca<sup>2+</sup> is recruited to the plasma membrane, where it interacts with the hydrophilic domain of PIP2 (specifically with the inositol ring), which is flanked toward the cytosol (<xref ref-type="bibr" rid="B45">Fukami et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). The active site of PLC has positively charged conserved amino acid residues, which are critically required to interact with the four and five positions of the inositol ring in PIP2 (<xref ref-type="bibr" rid="B74">Kim et&#xa0;al., 1991</xref>; <xref ref-type="bibr" rid="B38">Fanning and Anderson, 1996</xref>; <xref ref-type="bibr" rid="B48">Gifford et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B164">Wang et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). The interaction of PLC with PIP2 activates the 2-hydroxy group of the inositol ring, which further attacks 1-phosphate, leading to the formation of 1,2-cyclic phosphate and DAG intermediates. These cyclic intermediates get converted into an acyclic inositol derivative, which is referred to as IP3 (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). DAG, being a hydrophobic molecule, resides within the plasma membrane (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). IP3 and DAG act as secondary messengers and participate in downstream signaling processes (<xref ref-type="bibr" rid="B157">Titball, 1998</xref>; <xref ref-type="bibr" rid="B174">Williams, 1999</xref>; <xref ref-type="bibr" rid="B176">Wilton, 2008</xref>; <xref ref-type="bibr" rid="B71">Kadamur and Ross, 2013</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>; <xref ref-type="bibr" rid="B144">Stahelin, 2016</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Mechanism of PLC activation: ligand binding induces conformational changes in the receptor, leading to the activation of associated PLC. Activated PLC hydrolyzes the membrane-associated phosphatidylinositol 4,5-bisphosphate (PIP2) into di-acyl-glycerol (DAG) and inositol triphosphate (IP3). DAG, being a hydrophobic molecule, remains in the membrane and activates the protein kinase C (PKC)/transient receptor potential channel (TRPC)/chimeric (Rho GAP) proteins, resulting in the phosphorylation of several downstream effector molecules that are involved in regulating the relay of cellular functions (such as proliferation, polarity, learning, memory, and many more). DAG may also be cleaved to form another signal molecule, i.e., arachidonic acid. IP3 is released in the cytoplasm and binds to its receptor present on the smooth endoplasmic reticulum (SER) membrane (IP3 receptor), as a result of which Ca<sup>2+</sup> is released in cytosol from the SER. PLC, in association with intracellular Ca<sup>2+</sup>, is recruited to the plasma membrane, where it interacts with and cleaves the PIP2 molecule. Two positively charged amino acid residues are present in the active site of PLC and play a critical role in interaction with the four and five positions of the inositol ring to hydrolyze the PIP2 molecule. Furthermore, the 2&#x2019;-hydroxyl group attacks the 1&#x2019;-phosphate in order to release IP3 in the cytosol.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g002.tif"/>
</fig>
</sec>
<sec id="s3">
<title>Structure of different PLC isoforms</title>
<p>In mammals, 13 different PLC isozymes have been reported and are divided into six different subfamilies, namely &#x3b2;, &#x3b3;, &#x3b4;, &#x3b5;, &#x3b6;, and &#x3b7; (<xref ref-type="bibr" rid="B147">Suh et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B21">Bunney and Katan, 2011</xref>). The structural organization of PLC isozymes consists of various domains and motifs (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). However, the pleckstrin homology (PH) domain, EF-hand motifs, X and Y domains, and C2 domains show more than 40%&#x2013;50% similarity (<xref ref-type="bibr" rid="B45">Fukami et&#xa0;al., 2010</xref>). Core domains are present in all isoforms, whereas PLC-&#x3b6; is the only exception that does not contain the PH domain (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>) (<xref ref-type="bibr" rid="B21">Bunney and Katan, 2011</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Domain architecture present in different isoforms of PLC: all PLC isoforms have the core domains consisting of pleckstrin homology (PH) domain, EF-hand motifs, X and Y domains, and C2 domain (except in PLC-&#x3b6;). Additionally, CC and PDZ domains are present in PLC-&#x3b2; isoform. In PLC-&#x3b3;, X and Y domains are separated by two src homology 2 (SH2) domains followed by one src homology 3 (SH3) domain, which are present in between the additional PH domains. PLC-&#x3b4; comprises only the core domains. The Ras guanine exchange factor (GEF) domain is at the N-terminal tail, and the two RA domains are present at the C-terminal tail in PLC-&#x3b5;. PLC-&#x3b6; does not contain a PH domain. PLC-&#x3b7; consists of the core domains followed by the PDZ domain at the C-terminal tail.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g003.tif"/>
</fig>
<sec id="s3_1">
<title>PH domains</title>
<p>The N-termini of PLCs (except PLC-&#x3b6;) have the PH domain, which consists of ~120 amino acids. Several other protein families involved in signal transduction commonly have the PH domain in their structure (<xref ref-type="bibr" rid="B55">Harlan et&#xa0;al., 1994</xref>). The PH domain of PLC, in association with Ca<sup>2+</sup>, is recruited to the plasma membrane to establish the interaction with phosphoinositides (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>).</p>
</sec>
<sec id="s3_2">
<title>EF-hand motifs</title>
<p>The catalytic core of PLCs is composed of the EF-hand motifs, X and Y domains, and C2 domain (<xref ref-type="bibr" rid="B124">Rhee and Choi, 1992</xref>). Crystallographic analysis of PLC-&#x3b4;1 reveals that EF-hand motifs are helix-loop-helix motifs, generally present in calcium-binding proteins like calreticulin, calmodulin, and troponin (<xref ref-type="bibr" rid="B34">Essen et&#xa0;al., 1996</xref>). The binding of Ca<sup>2+</sup> leads to a conformational change in the EF-hand motif, as a result of which PLC stabilizes and then exposes the binding site for other proteins to further initiate the calcium-regulated functions and helps in signal transduction (<xref ref-type="bibr" rid="B124">Rhee and Choi, 1992</xref>). The binding of Ca<sup>2+</sup> promotes the interaction of the PH domain of PLC with PIP2 (<xref ref-type="bibr" rid="B35">Essen et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B114">Otterhag et&#xa0;al., 2001</xref>). However, it is not yet clear whether EF-hand motifs actually bind the Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>).</p>
</sec>
<sec id="s3_3">
<title>X and Y domains</title>
<p>Crystallographic studies of PLC-&#x3b4;1, PLC-&#x3b2;2, and PLC-&#x3b2;3 revealed that the X and Y domains are composed of ~300 amino acids, which lie at the C-terminal of EF-hand motifs (<xref ref-type="bibr" rid="B34">Essen et&#xa0;al., 1996</xref>; <xref ref-type="bibr" rid="B67">Jezyk et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B163">Waldo et&#xa0;al., 2010</xref>). An alternative arrangement of &#x3b1;-&#x3b2; structures in the X and Y domain forms a &#x3b2;&#x3b1;&#x3b2;&#x3b1;&#x3b2;&#x3b1;&#x3b2;&#x3b1; motif with a triose phosphate isomerase (TIM) barrel-like structure (<xref ref-type="bibr" rid="B34">Essen et&#xa0;al., 1996</xref>). The X-region contains histidine (His<sup>311</sup> and His<sup>356</sup>) as catalytic residues, which are required for the generation of 1,2-cyclic inositol 4,5-bisphosphate (<xref ref-type="bibr" rid="B32">Ellis MV and Katan, 1995</xref>; <xref ref-type="bibr" rid="B34">Essen et&#xa0;al., 1996</xref>; <xref ref-type="bibr" rid="B21">Bunney and Katan, 2011</xref>). These His<sup>311</sup> and His<sup>356</sup> residues are highly conserved across the PLC family members (<xref ref-type="bibr" rid="B32">Ellis MV and Katan, 1995</xref>). Structurally, the Y-region belongs to residues from 489 to 606 and plays an important part in substrate recognition (<xref ref-type="bibr" rid="B129">Ryu et&#xa0;al., 1987</xref>; <xref ref-type="bibr" rid="B174">Williams, 1999</xref>; <xref ref-type="bibr" rid="B103">Nagano et&#xa0;al., 2002</xref>). The X domain represents the first half while the Y domain represents the second half, of the TIM barrel-like structure (<xref ref-type="bibr" rid="B32">Ellis MV and Katan, 1995</xref>; <xref ref-type="bibr" rid="B103">Nagano et&#xa0;al., 2002</xref>). In PLC-&#x3b3;, the X and Y regions are separated by the two src homology 2 (SH2) domains at the N-terminal, followed by the src homology 3 (SH3) domain. The SH2 domain of PLC&#x3b3; serves as a docking site for phosphorylation and is activated by the tyrosine kinase growth factor receptor (<xref ref-type="bibr" rid="B162">Wahl et&#xa0;al., 1988</xref>; <xref ref-type="bibr" rid="B95">Meisenhelder et&#xa0;al., 1989</xref>; <xref ref-type="bibr" rid="B88">Margolis et&#xa0;al., 1990</xref>). The SH3 domain is responsible for the cellular localization of signaling proteins (<xref ref-type="bibr" rid="B14">Bar-Sagi et&#xa0;al., 1993</xref>; <xref ref-type="bibr" rid="B52">Gout et&#xa0;al., 1993</xref>).</p>
</sec>
<sec id="s3_4">
<title>C2 domains</title>
<p>More than 40 different proteins involved in signal transduction and membrane interactions are reported to have the C2 domain. It consists of ~120 amino acids and has binding sites for several proteins, through which they are engaged in signal transduction and membrane interaction processes. These domains form an eight-stranded antiparallel &#x3b2; sandwich complex (<xref ref-type="bibr" rid="B34">Essen et&#xa0;al., 1996</xref>). Three to four C2 domains were reported in PLC-<italic>&#x3b4;</italic> family members. The C2 domain operates in combination with Ca<sup>2+</sup>-mediated binding of PLC to anionic phospholipids and conducts signal transduction as well as membrane trafficking. Multiple binding sites for Ca<sup>2+</sup> on PLCs act synergistically to mediate diverse functions (<xref ref-type="bibr" rid="B35">Essen et&#xa0;al., 1997</xref>).</p>
</sec>
<sec id="s3_5">
<title>PDZ domains (postsynaptic density-95, <italic>Drosophila</italic> disc large tumor suppressor, and Zonula occludens-1 protein)</title>
<p>The PDZ domain is present at the C-terminal tail of PLC-&#x3b2; and PLC-&#x3b7; (<xref ref-type="bibr" rid="B38">Fanning and Anderson, 1996</xref>; <xref ref-type="bibr" rid="B161">Vines, 2012</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). The PDZ binding motifs are formed by two &#x3b1;-helices and five or six &#x3b2;-strands. PDZ domains are found in several signaling proteins other than PLCs (<xref ref-type="bibr" rid="B38">Fanning and Anderson, 1996</xref>). The PDZ domain serves as the binding site for large molecular complexes (<xref ref-type="bibr" rid="B164">Wang et&#xa0;al., 2010</xref>). Crystallographic and biochemical studies revealed that PDZ domains have two distinct mechanisms through which they interact either with the protein having the PDZ domain or bind with the C-terminal of an unrelated protein (<xref ref-type="bibr" rid="B38">Fanning and Anderson, 1996</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Isoforms of PLC</title>
<sec id="s4_1">
<title>PLC-&#x3b2; (1/2/3/4)</title>
<p>Several physical and chemical stimuli are received by the cells <italic>via</italic> receptors that are coupled to heterotrimeric G-protein (G<sub>&#x3b1;</sub>, G<sub>&#x3b2;</sub>, and G<sub>&#x3b3;</sub>). These stimuli lead to the activation of G<sub>&#x3b1;</sub>, causing PLC-&#x3b2; activation and the hydrolysis of PIP2 (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). There are four different isoforms of PLC-<italic>&#x3b2;</italic>, and the size varies from 130 to 152 kDa (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>). PLC-&#x3b2; isoforms are stimulated by G-proteins and Ca<sup>2+</sup>. PLC-<italic>&#x3b2;</italic> is expressed in a tissue-specific manner and shows different sensitivities toward G-protein-mediated activation (<xref ref-type="bibr" rid="B71">Kadamur and Ross, 2013</xref>). Each &#x3b2; isoform has many splice variants, but the functions of many of these variants are unknown (<xref ref-type="bibr" rid="B83">Lagercrantz et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B87">Mao et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B161">Vines, 2012</xref>). The C-terminal of PLC-<italic>&#x3b2;</italic> isoforms shows some differences, and the PLC-&#x3b2; subfamily has a unique 450-amino acid long C-terminal extension, but the significance of this difference is unknown. This extension contains signals for nuclear and cytoplasmic localization of PLC-<italic>&#x3b2;</italic>1b and PLC-<italic>&#x3b2;</italic>1a, respectively (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>). Regulation of PLC-<italic>&#x3b2;</italic> isoforms involves regulation by phosphatidic acid, a small GTP-binding protein (Rac), and site-specific phosphorylation by several kinases (<xref ref-type="bibr" rid="B71">Kadamur and Ross, 2013</xref>). Furthermore, PLC-<italic>&#x3b2;</italic> isoforms are involved in some physiological conditions such as epilepsy, abnormal functioning of neutrophils and platelets, hyper-responsiveness to opioid stimulation, ataxia, and impairment in visual perception (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>).</p>
</sec>
<sec id="s4_2">
<title>PLC-&#x3b3; (1/2)</title>
<p>Two isoforms of PLC-&#x3b3; are known as PLC-&#x3b3;1 and PLC-&#x3b3;2, with an approximate molecular weight of 140 kDa (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). Both isoforms are characterized by a large, unique multidomain X-Y linker that plays a significant role in its regulation and a split PH-domain including two SH2 domains (nSH2 and cSH2) and one SH3 domain. The structure and regulation of PLC-&#x3b3;1 and PLC-&#x3b3;2 seem to be similar in most cases (<xref ref-type="bibr" rid="B71">Kadamur and Ross, 2013</xref>). PLC-&#x3b3;1 is expressed ubiquitously and appears to be important for controlling cell growth and differentiation. PLC-&#x3b3;2 is primarily expressed in the cells of the hematopoietic lineage (<xref ref-type="bibr" rid="B18">Bonvini et&#xa0;al., 2003</xref>). Disruption of the PLC-&#x3b3;1 gene in mice is fatal at an early embryonic stage. Loss of the PLC-&#x3b3;2 gene is not fatal but results in impairment of B-cell maturation, leading to immunodeficient conditions and defective Fc-receptor-mediated signaling in platelets and mast cells (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>).</p>
</sec>
<sec id="s4_3">
<title>PLC-&#x3b4; (1/3/4)</title>
<p>PLC-&#x3b4; was originally identified in bovine as PLC-&#x3b4;2, but later it was found to be homologous to humans and mouse PLC-&#x3b4;4 (<xref ref-type="bibr" rid="B65">Irino et al., 2004</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). Three isoforms of PLC-&#x3b4; (PLC-&#x3b4;1, PLC-&#x3b4;3, and PLC-&#x3b4;4) have been identified with an approximate molecular weight of 90 kDa. PLC-&#x3b4; isoforms have simpler structures compared to the other PLC isozymes (<xref ref-type="bibr" rid="B96">Meldrum et al., 1991</xref>; <xref ref-type="bibr" rid="B65">Irino et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). PLC-&#x3b4; isoforms show greater sensitivity to Ca<sup>2+</sup> in comparison to &#x3b2; and &#x3b3; isozymes, suggesting Ca<sup>2+</sup> is essential for &#x3b4;-isozyme activity (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). PLC-&#x3b4; is activated following an increase in the cytoplasmic Ca<sup>2+</sup> concentration. The PH domain of PLC-&#x3b4; binds PIP2 on the plasma membrane (<xref ref-type="bibr" rid="B3">Allen et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B75">Kim et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). After substrate hydrolysis, PLC-&#x3b4; also interacts with IP3 with a higher affinity, causing the dissociation of membrane-bound PLC-&#x3b4; and making it inactive, thus acting as a negative feedback regulation system (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>). Although PLC-&#x3b4; is not essential, misregulation of certain isoforms leads to some abnormal conditions. Deregulation of PLC-&#x3b4;1 has been associated with Alzheimer&#x2019;s disease and hypertension (<xref ref-type="bibr" rid="B136">Shimohama et&#xa0;al., 1991</xref>; <xref ref-type="bibr" rid="B181">Yagisawa et&#xa0;al., 1991</xref>). PLC-&#x3b4;1 deficiency in mice caused them to look like nude mice. Expression of the PLC-&#x3b4;1 was reportedly higher in hair follicles, and homozygous gene deletion resulted in hair loss (<xref ref-type="bibr" rid="B63">Ichinohe et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B105">Nakamura et al., 2008</xref>). Deletion of PLC-&#x3b4;3 or PLC-&#x3b4;4 genes showed no phenotypic effects in mice, but sperms from PLC-&#x3b4;4-deficient mice showed a defective acrosomal reaction, a process required for fertilization (<xref ref-type="bibr" rid="B46">Fukami et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B47">Fukami et&#xa0;al., 2003</xref>).</p>
</sec>
<sec id="s4_4">
<title>PLC-&#x3b5;</title>
<p>PLC-&#x3b5;, first identified in <italic>Caenorhabditis elegans</italic>, is the largest PLC isoform cloned to date, with a molecular weight of 250 kDa. The N-terminal of PLC-&#x3b5; contains CDC 25-like guanine exchange factor (GEF) domain followed by core elements and the C2 domain followed by two copies of Ras binding (RA) domains. Later, this PLC isoform was cloned from human cells, where it has been recognized as a Ras-activated isoform that works in association with the RA domain. The RA domain of PLC-&#x3b5; directly interacts with Ras, Ras family GTPases, and Rho (<xref ref-type="bibr" rid="B72">Kelley et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B142">Song et&#xa0;al., 2001</xref>). Regulation of the activity of PLC-&#x3b5; by Ras and Rho suggests its role in the proliferation and migration of cells (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>). Unlike other isoforms of PLC, it is activated not only by heterotrimeric G-protein but also by small GTPases (<xref ref-type="bibr" rid="B142">Song et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B161">Vines, 2012</xref>). Knockout of PLC-&#x3b5; in mice showed impaired development of the heart and its functioning (<xref ref-type="bibr" rid="B134">Sekiya, 2013</xref>).</p>
</sec>
<sec id="s4_5">
<title>PLC-&#x3b6;</title>
<p>PLC-&#x3b6; was first reported in the sperm head, where it serves a crucial role in the activation of oocytes during fertilization (<xref ref-type="bibr" rid="B69">Jones et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B26">Cox et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B131">Saunders et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B44">Fujimoto et&#xa0;al., 2004</xref>). Sperm-specific PLC-&#x3b6; regulates the oscillation of Ca<sup>+2</sup> in the cytoplasm of fertilizing eggs (<xref ref-type="bibr" rid="B26">Cox et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B131">Saunders et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B150">Swann et&#xa0;al., 2006</xref>). PLC-&#x3b6; is the only PLC isoform without the PH domain and shows the closest homology with PLC-&#x3b4;1 (<xref ref-type="bibr" rid="B150">Swann et&#xa0;al., 2006</xref>). The PH domain is not required for the membrane localization of PLC-&#x3b6;. However, it is not yet known how PLC-&#x3b6; associates with the cell membrane without the PH domain and catalyzes the reaction (<xref ref-type="bibr" rid="B161">Vines, 2012</xref>). Loss of PLC-&#x3b6; affects male fertility (<xref ref-type="bibr" rid="B183">Yoon et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B60">Heytens et&#xa0;al., 2009</xref>).</p>
</sec>
<sec id="s4_6">
<title>PLC-&#x3b7; (1/2)</title>
<p>Two isoforms of PLC-<italic>&#x3b7;</italic>, i.e., PLC-&#x3b7;1 and PLC-&#x3b7;2 have been reported with an apparent molecular weight of 115 kDa and 125 kDa respectively (<xref ref-type="bibr" rid="B62">Hwang et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B145">Stewart et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B184">Zhou et&#xa0;al., 2005</xref>). Both show ~ 50% sequence homology with each other and are expressed in neurons and the brain (<xref ref-type="bibr" rid="B62">Hwang et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B104">Nakahara et&#xa0;al., 2005</xref>). PLC-&#x3b7; shows extremely higher sensitivity towards changes in the Ca<sup>2+</sup> level, even when compared with PLC-<italic>&#x3b4;</italic> (<xref ref-type="bibr" rid="B184">Zhou et&#xa0;al., 2005</xref>). In humans, deletion of chromosomal region encoding for PLC-&#x3b7;2 might be linked to intellectual disability (<xref ref-type="bibr" rid="B86">Lo Vasco, 2011</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Role of PLC in bacteria</title>
<p>PLCs are essential virulence factors in many bacteria as they contribute to the avoidance of phagosomal maturation or phagosomal escape, tissue colonization, establishment of infection, and pathogenesis. In this section, we will discuss the specific roles of PLCs in various infections caused by pathogenic bacteria.</p>
</sec>
<sec id="s6">
<title>Role of PLC in <italic>Clostridium perfringens</italic> infection</title>
<p>
<italic>Clostridium perfringens</italic> (<italic>C. perfringens</italic>) is an anaerobic spore-forming bacterium extensively distributed in nature. <italic>C. perfringens</italic> is found in soil, sewage, and the gastrointestinal tract of humans and other animals (<xref ref-type="bibr" rid="B40">Flores-D&#xed;az and Alape-Gir&#xf3;n, 2003</xref>; <xref ref-type="bibr" rid="B76">Kiu and Hall, 2018</xref>). <italic>C. perfringens</italic> causes various human diseases such as gas gangrene or myonecrosis and represents the most severe, sudden onset gram-positive bacterial infection. Gas gangrene is a pathological condition when healthy, viable tissues are damaged rapidly. Amputation of the affected tissue is the only option to save the life of an infected individual (<xref ref-type="bibr" rid="B101">Monturiol-Gross et&#xa0;al., 2014</xref>).</p>
<p>
<italic>C. perfringens</italic> PLC, also referred to as &#x3b1;-toxin, is a 42.5-kDa protein with 370-amino acid residues. Clostridial PLC is an extracellular Zn<sup>2+</sup> metalloenzyme that mainly hydrolyzes PC and sphingomyelin (<xref ref-type="bibr" rid="B107">Naylor et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B2">Alape-Gir&#xf3;n et&#xa0;al., 2000</xref>). The &#x3b1;-toxin is a critically important virulence factor for the pathogenesis of gas gangrene. The &#x3b1;-toxin causes the aggregation of platelets and has myotoxic and cytotoxic lethal effects (<xref ref-type="bibr" rid="B2">Alape-Gir&#xf3;n et&#xa0;al., 2000</xref>). 3-D structure analysis of &#x3b1;-toxin revealed that it is composed of two domains joined together by a short hinge region. The N-terminal domain (246 residues) comprises the active site consists of 10 tightly packed &#x3b1;-helices while the C-terminal domain (124 residues) is composed of four-stranded sandwiched &#x3b2;-sheets (<xref ref-type="bibr" rid="B107">Naylor et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>). The N-terminal domain is the catalytic domain for which Zn<sup>2+</sup> is essential. The C-terminal domain shows strong structural similarities with the C2 domain of eukaryotic PLCs and is responsible for the binding of &#x3b1;-toxin to phospholipids on membranes in Ca<sup>2+</sup>-dependent manner. Such domains are frequently present in protein functioning as a secondary messenger (<xref ref-type="bibr" rid="B107">Naylor et&#xa0;al., 1998</xref>).</p>
<p>Some researchers suggest that &#x3b1;-toxin can be present in two conformations: the first one is an open conformation in which three Zn<sup>2+</sup> ions are bound to make the active site accessible, while the second one is a closed conformation in which two Zn<sup>2+</sup> ions are bound and the active site is masked by 135&#x2013;150-amino acid residues (<xref ref-type="bibr" rid="B2">Alape-Gir&#xf3;n et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B41">Flores-D&#xed;az et&#xa0;al., 2005</xref>). Specific binding of the C-terminal domain to the target membrane leads to conformational changes within the structure of &#x3b1;-toxin. Through these changes, the active site is exposed, allowing catalysis to occur (<xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>).</p>
<p>
<italic>C. perfringens</italic> enters inside the host <italic>via</italic> wounds and starts growing rapidly, producing &#x3b1;-toxin. &#x3b1;-toxin plays a key role in spreading the infection by suppressing the host&#x2019;s immune response. &#x3b1;-toxin also triggers the release of inflammatory mediators and changes the intracellular Ca<sup>2+</sup> level (<xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>). Calcium and zinc ions are essential for the &#x3b1;-toxin to bind with lipids on the cell membrane and hydrolyze the substrate, respectively (<xref ref-type="bibr" rid="B102">Moreau et&#xa0;al., 1988</xref>). The binding of calcium ions allows the formation of a hydrogen bond between Tyr62 of the N-terminal domain with Asn294 of the C-terminal domain, which is required for the C-terminal domain to communicate with the active site (<xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>).</p>
<p>Higher cellular levels of &#x3b1;-toxin disrupt the plasma membrane, causing cytolysis, while at low levels perturb phospholipid metabolism, impair various signal transduction processes, and induce the unregulated generation of secondary messengers (<xref ref-type="bibr" rid="B43">Flores-D&#xed;az et&#xa0;al., 2004</xref>). Mutants with insertional inactivation of the &#x3b1;-toxin gene were not able to produce an active form of toxin and are unable to cause gas gangrene (<xref ref-type="bibr" rid="B8">Awad et&#xa0;al., 1995</xref>). Immunization of mice with a fragment of &#x3b1;-toxin consisting of the C-terminal domain protects them from a lethal myonecrosis infection (<xref ref-type="bibr" rid="B108">Naylor et&#xa0;al., 1999</xref>). These findings suggest that &#x3b1;-toxin of <italic>C. perfringens</italic>  play a critical role in its pathogenesis (<xref ref-type="bibr" rid="B8">Awad et&#xa0;al., 1995</xref>).</p>
<p>&#x3b1;-toxin shows diverse roles depending on the cell types. In intestinal epithelial cells, it induces the release of arachidonic acid by activating the host-specific phospholipase A2; because of this event, PI gets degraded and the activation of protein kinase C (PKC) and calmodulin takes place. &#x3b1;-toxin elevates the levels of intracellular free Ca<sup>2+</sup>, which may be responsible for PKC activation (<xref ref-type="bibr" rid="B54">Gustafson and Tagesson, 1990</xref>). In rabbit neutrophils, &#x3b1;-toxin interacts with the tropomyosin receptor kinase A (TrkA receptor) and host PLC. While its interaction with TrkA phosphorylates the 3-phosphoinositide-dependent protein kinase 1 (PDK1), its interaction with the host PLC induces the formation of DAG. DAG and the PDK1 synergistically activate the PKC to produce the superoxide anions (<inline-formula>
<mml:math display="inline" id="im1">
<mml:mrow>
<mml:msubsup>
<mml:mtext>O</mml:mtext>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>) through the activation of the MEK/extracellular signal-regulated kinases (ERK) pathway (<xref ref-type="bibr" rid="B110">Oda et&#xa0;al., 2006</xref>).</p>
<p>&#x3b1;-toxin induces the recruitment of neutrophils on vascular endothelium, especially in the lungs and liver (<xref ref-type="bibr" rid="B111">Oda et&#xa0;al., 2012</xref>), leading to the formation of blood clots. This results in the reduced supply of oxygen in the tissues, favoring anaerobic conditions. This enhances the outspread of <italic>C. perfringens</italic> within the host tissues (<xref ref-type="bibr" rid="B43">Flores-D&#xed;az et&#xa0;al., 2004</xref>).</p>
<p>&#x3b1;-toxin signal is communicated through membrane receptors and their nuclear or cytoplasmic targets <italic>via</italic> various pathways, including the MAPK pathway (<xref ref-type="bibr" rid="B178">Wortzel and Seger, 2011</xref>). The &#x3b1;-toxin simultaneously activates the ERK1/2-nuclear factor-kB (NF-kB) and p38 mitogen-activated protein kinases (MAPK) cascades, which promote the expression and stabilization of interleukin-8, respectively (<xref ref-type="bibr" rid="B111">Oda et&#xa0;al., 2012</xref>). Many cellular processes are regulated by the ERK1/2 signaling cascade, such as proliferation, differentiation, survival, and apoptosis, as well as the stress response (<xref ref-type="bibr" rid="B178">Wortzel and Seger, 2011</xref>). Deregulation of the ERK1/2 signaling cascade is associated with various diseases like neurodegenerative diseases, developmental diseases, diabetes, and cancer (<xref ref-type="bibr" rid="B151">Tanti and Jager, 2009</xref>; <xref ref-type="bibr" rid="B154">Tidyman and Rauen, 2009</xref>; <xref ref-type="bibr" rid="B73">Kim and Choi, 2010</xref>; <xref ref-type="bibr" rid="B178">Wortzel and Seger, 2011</xref>).</p>
<p>In diabetic animals, the UDP-glucose levels are low in tissues, and these tissues are hypersensitive to the cytotoxic effects of &#x3b1;-toxin through some unknown mechanism (<xref ref-type="bibr" rid="B42">Flores-D&#xed;az et&#xa0;al., 1998</xref>). Gangliosides protect cell membrane disruption induced by &#x3b1;-toxin. Muscles generally have a lower amount of complex gangliosides among mammalian tissues, explaining their higher susceptibility to rapid and extensive damage caused by &#x3b1;-toxin and the release of creatine kinase in plasma (<xref ref-type="bibr" rid="B41">Flores-D&#xed;az et&#xa0;al., 2005</xref>). The mechanism of ganglioside-mediated protection from &#x3b1;-toxin and the higher sensitivity of tissues with low UDP-glucose for &#x3b1;-toxin-mediated cytotoxicity remain to be explored.</p>
<sec id="s6_1">
<title>PLC regulates phagocytosis, intracellular survival, and immune response during mycobacterial infections</title>
<p>
<italic>Mycobacterium tuberculosis</italic> (Mtb) is an acid-fast, rod-shaped, nonmotile, nonspore-forming, catalase-positive bacteria that ranges from 0.2 to 0.6&#x3bc;m in diameter and 1.0 to 10 &#x3bc;m in length. Different mycobacterial strains produce distinct morphological colonies varying from smooth to rough surfaces (<xref ref-type="bibr" rid="B51">Gordon and Parish, 2018</xref>). They also have distinct colony colors ranging from white to orange or pink (<xref ref-type="bibr" rid="B64">Iivanainen et&#xa0;al., 1999</xref>). Most of the mycobacterial strains are aerobic in nature, while some of them are microaerophilic (<xref ref-type="bibr" rid="B37">Falkinham, 1996</xref>).</p>
<p>Approximately 130 mycobacterial species are harmless to humans, but a few of them are among the major threats to human health and life. Mtb survives and multiplies inside the host macrophages by manipulating their machinery, leading to active tuberculosis (TB) development. Lipid metabolism is thought to be the central metabolic pathway among mycobacterial species (<xref ref-type="bibr" rid="B9">Bakala N'goma et&#xa0;al., 2010</xref>). Mycobacterial pathogens conceal themselves from the host&#x2019;s defense system and harmonize their gene expression according to the intracellular environment (<xref ref-type="bibr" rid="B149">Sundararajan and Muniyan, 2021</xref>).</p>
<p>Mtb infects the macrophages by exploiting their phagocytic nature and is able to persist the infection in a state of dormancy by forming granulomas within the host (<xref ref-type="bibr" rid="B169">Wayne and Sohaskey, 2001</xref>). Before entering the dormant stage, Mtb starts to accumulate the lipids derived from the host cell membrane degradation and later hydrolyze them to reactivate the infection process. Lipolytic enzymes such as PLCs might be required for the degradation of the macrophage&#x2019;s membrane (<xref ref-type="bibr" rid="B24">C&#xf4;tes et&#xa0;al., 2008</xref>). Various studies on PLCs derived from both the host and the pathogen showed their significant role during bacterial pathogenesis (<xref ref-type="bibr" rid="B143">Songer, 1997</xref>; <xref ref-type="bibr" rid="B123">Raynaud et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B122">Poussin et&#xa0;al., 2009</xref>).</p>
<p>Mtb contains four closely related genes encoding putative PLCs; PLC-A, PLC-B, PLC-C, and PLC-D (<xref ref-type="bibr" rid="B123">Raynaud et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B84">Le Chevalier et&#xa0;al., 2015</xref>). PLC is a critical virulence factor and is important for persistent infection. Genetic studies using PLC mutant strains established that all four PLC genes encode functional enzymes that are capable of hydrolyzing their PC-like substrates (<xref ref-type="bibr" rid="B123">Raynaud et&#xa0;al., 2002</xref>).</p>
<p>
<italic>Mycobacterium smegmatis</italic> (MS) was used as the expression system to produce active soluble recombinant PLC from Mtb that was expressed at very low levels, therefore the biochemical properties and the substrate specificity of Mtb&#x2019;s PLCs are yet to be determined (<xref ref-type="bibr" rid="B68">Johansen et&#xa0;al., 1996</xref>). To analyze the role of mycobacterial PLC in macrophage cytotoxicity, Assis and co-workers used two different groups of isolates. Group A consisted of Mtb isolates expressing PLC, while group B consisted of Mtb isolates that do not express PLC; 24&#xa0;h postinfection, groups A and B isolates of infected rat alveolar macrophages showed a 40% and 20% reduction in cell viability, respectively. This indicates that mycobacterial PLC has cytotoxic effects. Group A-infected host cells were detected with a higher number of kinase phosphorylated proteins, which are known to play several roles in intracellular signaling pathways. It was also observed that group A-infected cells released significantly higher levels of proinflammatory cytokines and nitric oxide (NO) as compared to group B-infected or noninfected cells. These data suggest that the alveolar macrophage activation and the production of pro-inflammatory cytokines might be induced by the PLC of mycobacterial origin. To evaluate the role of PLC in subverting host biosynthetic pathways as a strategy employed by mycobacteria to evade the host immune response, the mRNA expression of host enzymes and receptors involved (eicosanoid biosynthesis pathways like cyclooxygenase-2 (COX-2), prostaglandin E<sub>2</sub> receptor 2 (EP-2) and prostaglandin E<sub>2</sub> receptor 4 (EP-4), and leukotriene B4 (LTB4)) were analyzed. Expression of COX-2, EP-2, and EP-4 was found to be lower in group A-infected cells as compared to group B-infected cells, while higher expression of LTB4 was observed in group A-infected cells. These data suggest impairment of the eicosanoid biosynthesis pathway by mycobacterial PLC, which may help Mtb escape from the host&#x2019;s immune response. No difference in apoptotic activity was observed in both groups A and B isolates, while necrosis was significantly higher in group A-infected macrophages. This effect was abolished by the treatment of group A isolates with PLC inhibitors&#x2014;D609 and U73122, suggesting the possibility that mycobacterial PLC might induce necrosis in host cells (<xref ref-type="bibr" rid="B5">Assis et&#xa0;al., 2014</xref>). Host-derived PLC plays a very important role in mycobacterial infections and pathogenesis (<xref ref-type="bibr" rid="B148">Sukumaran et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B11">Bandyopadhaya et&#xa0;al., 2009</xref>). Knockdown of host PLC-&#x3b3;1 using si-RNA caused increased phagocytosis and reduced intracellular survival of both MS and Mtb in J774A1 cells. PLC-&#x3b3;1-deficient cell also expressed higher levels of tumor necrosis factor-&#x3b1; (TNF-&#x3b1;) and RANTES during Mtb infection. These observations suggest an important role of PLC-&#x3b3;1 in mycobacterial infection (<xref ref-type="bibr" rid="B117">Paroha et&#xa0;al., 2020</xref>). Another study conducted by the same group also reported that the knockdown of host PLC-&#x3b3;2 in J774A1 cells increased phagocytosis and reduced intracellular survival of Mtb. PLC-&#x3b3;2-deficient cells also show increased expression of pro-inflammatory cytokines during Mtb infection. In the same study, increased PLC-&#x3b3;2 phosphorylation during Mtb but not in MS was also reported. These studies suggest that different PLC isoforms may be involved in the regulation of mycobacterial infection (<xref ref-type="bibr" rid="B116">Paroha et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B117">Paroha et&#xa0;al., 2020</xref>). However, the mechanism of PLC phosphorylation during Mtb infection remains to be determined and represents a promising area of investigation.</p>
<p>It was reported that when human neutrophils were infected with Mtb Ra, an avirulent derivative of Mtb H37Rv, it promoted the production of reactive oxygen intermediate (ROI) through tyrosine phosphorylation of PLC-&#x3b3;2 by a tyrosine kinase. Inhibition of PLC-&#x3b3;2 results in reduced ROI production induced by Mtb (<xref ref-type="bibr" rid="B119">Perskvist et&#xa0;al., 2000</xref>). To regulate the cytokine production in alveolar macrophages and epithelial cells, transient receptor potential channel-1 (TRPC-1) and its associated endogenous Ca<sup>2+</sup> channel play an important role. TRPC-1 allows the entry of Ca<sup>2+</sup> inside the macrophage, which leads to an intense inflammatory response and increases infection susceptibility as compared to the TRPC-1-deficient cells. Activation of PLC-&#x3b3; in these cells induces the phosphorylation of PKC-&#x3b1;, leading to the translocation of NF-&#x3ba;B and Jun N-terminal protein kinase (JNK) inside the nucleus, resulting in increased production of inflammatory cytokines (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Thus, an increased level of inflammatory cytokines might provide protection from invading pathogens (<xref ref-type="bibr" rid="B185">Zhou et&#xa0;al., 2015</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>
<italic>Mycobacterium tuberculosis</italic> (Mtb) infection perturbs host PLC signaling: infections of macrophage with Mtb selectively activate/deactivate PLC isoforms. PLC-&#x3b3;2 is activated following Mtb infection while PLC-&#x3b3;1 expression is reduced in host cells. These perturbations in host PLC signaling result in poor bactericidal responses by macrophages.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g004.tif"/>
</fig>
<p>After recognition of mycobacteria by macrophages, the secretion of pro-inflammatory cytokines (like TNF-&#x3b1; and RANTES) and chemokines is an important step to mediate the immune response against the bacilli. Treatment with PLC inhibitors showed an inhibitory effect on the secretion of pro-inflammatory cytokines, suggesting that PLC signaling in macrophages might regulate the immune response against the mycobacteria (<xref ref-type="bibr" rid="B180">Yadav et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B117">Paroha et&#xa0;al., 2020</xref>).</p>
<p>During infection of macrophages by Mtb, the expression of the plc operon in Mtb was significantly upregulated for 24&#xa0;h of infection (<xref ref-type="bibr" rid="B123">Raynaud et&#xa0;al., 2002</xref>). Available literature suggests that the PLC of mycobacterial origin is involved in pathogenicity, but some contrary studies are also reported, and further investigations are required to clearly understand the role of PLC in the virulence of Mtb (<xref ref-type="bibr" rid="B84">Le Chevalier et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s6_2">
<title>
<italic>Listeria monocytogenes</italic> PLC is required to protect pathogens from host autophagy destruction and promote cell-to-cell transmission</title>
<p>
<italic>Listeria monocytogenes</italic> (<italic>L. monocytogenes</italic>) is a facultative intracellular gram-positive, rod-shaped pathogen that can cause serious infections in humans and domestic animals (<xref ref-type="bibr" rid="B28">Dabiri et&#xa0;al., 1990</xref>; <xref ref-type="bibr" rid="B140">Smith et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B143">Songer, 1997</xref>; <xref ref-type="bibr" rid="B133">Schlech and Acheson, 2000</xref>). This pathogen has a remarkable capability to multiply and spread from cell to cell without exposure to the extracellular environment. To gain entry into host cells, <italic>L. monocytogenes</italic> induces the phagocytic as well as nonphagocytic cells for its internalization (<xref ref-type="bibr" rid="B152">Tattoli et&#xa0;al., 2013</xref>).</p>
<p>The practice of living as a pathogen within the host can be divided into six junctures, including (i) the association of bacterium with microvilli on the plasma membrane, (ii) internalization by professional and non-professional phagocytes, (iii) escape from the entry vacuole, (iv) replication in the cytosol, (v) propelled to the cell surface with the help of host actin filaments and form pseudopod-like structure, and (vi) spread through the cell to cell, forming a double-membrane vacuole <bold>(</bold>
<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>
<bold>)</bold> (<xref ref-type="bibr" rid="B155">Tilney and Portnoy, 1989</xref>; <xref ref-type="bibr" rid="B122">Poussin et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B152">Tattoli et&#xa0;al., 2013</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>PLC-A and PLC-B promote cell-to-cell spread during <italic>Listeria monocytogenes</italic> infection: After internalization by the host immune cells, <italic>L. monocytogenes</italic> is present inside the primary vacuole. The <italic>L. monocytogenes</italic> (WT) has the ability to lyse the primary vacuole and escape into the host cytosol, where it is free to propel to the host cell surface through the host-specific actin filament and form pseudopod-like structures, allowing them to spread from one cell to another <italic>via</italic> insert forming double-membrane vacuole. Again, the <italic>L. monocytogenes</italic> lyses the double-membrane vacuole to further infect the nearby cells. While the <italic>L. monocytogenes</italic>&#x394;<italic>plcA</italic> shows an impaired ability to escape from the primary vacuole, <italic>L. monocytogenes</italic> &#x394;<italic>plcB</italic> shows reduced potential to escape from the double-membrane vacuole.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g005.tif"/>
</fig>
<p>
<italic>L. monocytogenes</italic> has evolved to subvert the autophagy flux in the infected cells through PLC activity (<xref ref-type="bibr" rid="B152">Tattoli et&#xa0;al., 2013</xref>). PLC produced by <italic>L. monocytogenes</italic> plays a significant role in escaping from the entry vacuole and also helps the pathogen spread from one cell to another cell (<xref ref-type="bibr" rid="B140">Smith et&#xa0;al., 1995</xref>). PI-PLC and PC-PLC are encoded by <italic>plcA</italic> and <italic>plcB</italic> genes, respectively (<xref ref-type="bibr" rid="B22">Camilli et&#xa0;al., 1993</xref>; <xref ref-type="bibr" rid="B140">Smith et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B152">Tattoli et&#xa0;al., 2013</xref>). PI-PLC is secreted in an active form, whereas PC-PLC is secreted as an inactive proenzyme in the cytosol of infected host cells and rapidly degraded by the proteasome. PC-PLC is activated by metalloprotease, another enzyme secreted by the pathogen (<xref ref-type="bibr" rid="B90">Marquis et&#xa0;al., 1997</xref>).</p>
<p>For the pathogenesis of <italic>L. monocytogenes</italic>, several contiguous genes are reported to be required, which are organized in the following sequence on the regulon: <italic>prfA plcA</italic>, <italic>holy</italic>, <italic>mpl</italic>, <italic>actA</italic>, and <italic>plcB</italic> <bold>(</bold>
<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>)</bold> (<xref ref-type="bibr" rid="B121">Portnoy et&#xa0;al., 1992</xref>). PI-PLC has a dual role in pathogenesis. It positively regulates the expression of the <italic>prfA</italic> gene, the product of which regulates the expression of genes imperative for efficient cell-cell spread (<xref ref-type="bibr" rid="B98">Mengaud et&#xa0;al., 1989</xref>; <xref ref-type="bibr" rid="B97">Mengaud et&#xa0;al., 1991</xref>). PI-PLC is also required for bacterial growth in the murine liver. <italic>In vivo</italic>, the precise molecular events occurring during the action of PI-PLC are not yet clear, but some studies suggest that PI-PLC mediates the systematic lysis of host phagolysosome (<xref ref-type="bibr" rid="B22">Camilli et&#xa0;al., 1993</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Several genes and their functions are involved during the pathogenesis of <italic>L. monocytogenes</italic>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Sr. No.</th>
<th valign="top" align="center">Gene name</th>
<th valign="top" align="center">Gene function</th>
<th valign="top" align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1.</td>
<td valign="top" align="left">
<italic>inlA</italic>
</td>
<td valign="top" align="left">Responsible for the internalization of the bacteria.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B127">Roche et al., 2009</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">2.</td>
<td valign="top" align="left">
<italic>hly</italic>
</td>
<td valign="top" align="left">Encodes the listeriolysin-<italic>O</italic> (pore-forming cytolysin, evolved for activity in a phagosome having low optimum pH) and helps the bacterium to escape from the vacuole.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B49">Glomski et al., 2002</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">3.</td>
<td valign="top" align="left">
<italic>actA</italic>
</td>
<td valign="top" align="left">Surface protein induces the host cell to polymerize the actin filament.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B127">Roche et al., 2009</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">4.</td>
<td valign="top" align="left">
<italic>plcA</italic>
</td>
<td valign="top" align="left">Might help to escape the bacterium from the phagolysosomal vacuole.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B22">Camilli et&#xa0;al., 1993</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">5.</td>
<td valign="top" align="left">
<italic>plcB</italic>
</td>
<td valign="top" align="left">Might help the bacterium to escape from the double-membraned structure and also helps in cell-to-cell spread.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B127">Roche et al., 2009</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">6.</td>
<td valign="top" align="left">
<italic>prfA</italic>
</td>
<td valign="top" align="left">Positive regulatory factor acts as a transcription factor.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B22">Camilli et&#xa0;al., 1993</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">7.</td>
<td valign="top" align="left">
<italic>mpl</italic>
</td>
<td valign="top" align="left">Encodes the metalloprotease, which converts the 33-kDa inactive form of PC-PLC into the 28-kDa active form of PC-PLC.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B22">Camilli et&#xa0;al., 1993</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Intracellular pathogens like <italic>L. monocytogenes</italic> exploit the host processes to progress pathogenesis in a regulated manner. Depending on the subcellular localization of bacteria, two types of regulation may occur (<xref ref-type="bibr" rid="B90">Marquis et&#xa0;al., 1997</xref>). The proteolytic activation of the inactive form of PC-PLC in vacuoles occurs by bacterial proteases, leading to the acidification of the vacuole, whereas the host proteases degrade inactive PC-PLC in the cytosol. As a result of this, PC-PLC shows a short half-life (&lt;15&#xa0;min) and is essentially present in its inactive form within the cytosol. Interestingly, when the degradation of the inactive form of PC-PLC was inhibited, no mature PC-PLC was detectable in the cytosol (<xref ref-type="bibr" rid="B128">Rock et al., 1994</xref>; <xref ref-type="bibr" rid="B90">Marquis et al., 1997</xref>. There may be two mechanisms through which the production of active PC-PLC in the cytosol can be prevented: degradation or lack of activation (<xref ref-type="bibr" rid="B90">Marquis et&#xa0;al., 1997</xref>). Thus, these observations suggest that the activity of PC-PLC is restricted to the vacuolar compartment (<xref ref-type="bibr" rid="B140">Smith et&#xa0;al., 1995</xref>).</p>
<p>Regulated proteolysis and the optimum pH are required by the bacterial virulence factors to easily execute the cell-cell spread, causing the least damage to the host cell otherwise caused by listeriolysin-<italic>O</italic> cytotoxicity (<xref ref-type="bibr" rid="B70">Jones et al., 1996</xref>).</p>
<p>Both the phospholipases, plcA and plcB, have overlapping functions in the pathogenesis of <italic>L. monocytogenes</italic> infections. <italic>plcA</italic> mutant showed a slightly reduced capability to escape from the primary vacuole and three-fold less virulence than its wild-type counterpart <italic>plcB</italic> mutant was reported to have decreased potential to escape from the double membraned vacuole structure with 20-fold less virulence and has no measurable defects in escape from a primary vacuole. Indeed, the mutant lacking both PLCs was severely impaired in its ability to escape from the primary vacuoles and cell&#x2013;cell spread and was 500-fold less virulent (<xref ref-type="bibr" rid="B140">Smith et&#xa0;al., 1995</xref>).</p>
<p>Levels of DAG and ceramide were substantially increased in the host cells 4 to 5&#xa0;h postinfection with <italic>L. monocytogenes</italic>. Such an increase in the levels of DAG and ceramide may be attributed to PLCs derived from pathogens, as the plcA:plcB double mutant of <italic>L. monocytogenes</italic> failed to increase the levels of DAG and ceramide (<xref ref-type="bibr" rid="B140">Smith et al., 1995</xref>).</p>
</sec>
<sec id="s6_3">
<title>PLC promotes pathogen colonization and lung inflammation during <italic>Pseudomonas aeruginosa</italic> infection</title>
<p>
<italic>Pseudomonas aeruginosa</italic> (<italic>P. aeruginosa</italic>) is a gram-negative, opportunistic pathogen that causes a wide array of acute (sepsis) and chronic infections (pulmonary), including cystic fibrosis (CF), chronic wound infections, and postsurgical infections, especially in immunocompromised individuals (<xref ref-type="bibr" rid="B158">Vasil et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B165">Wargo et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B179">Wu et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B31">Diggle and Whiteley, 2020</xref>). PLCs contributed to multiple aspects of <italic>P. aeruginosa</italic> pathogenesis (<xref ref-type="bibr" rid="B16">Berk et al., 1987</xref>). <italic>P. aeruginosa</italic> expresses three extracellular PLCs: the hemolytic PLC known as PlcH and the nonhemolytic PlcN and PlcB (<xref ref-type="bibr" rid="B113">Ostroff and Vasil, 1987</xref>; <xref ref-type="bibr" rid="B12">Barker et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B166">Wargo et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B78">Klockgether and T&#xfc;mmler, 2017</xref>). While PlcH and PlcN are secreted through the twin-arginine translocase (TAT) secretory system, PlcB is secreted through the Sec pathway (<xref ref-type="bibr" rid="B109">Ochsner et al., 2002</xref>; <xref ref-type="bibr" rid="B12">Barker et al., 2004</xref>; <xref ref-type="bibr" rid="B141">Snyder et al., 2006</xref>). All the PLCs from <italic>P. aeruginosa</italic> can cleave PC, but only PlcB can hydrolyze phosphatidylethanolamine (<xref ref-type="bibr" rid="B33">Esselmann and Liu, 1961</xref>; <xref ref-type="bibr" rid="B109">Ochsner et al., 2002</xref>; <xref ref-type="bibr" rid="B12">Barker et al., 2004</xref>; <xref ref-type="bibr" rid="B141">Snyder et al., 2006</xref>).</p>
<p>The heterodimeric complex of novel PlcHR consists of two subunits: PlcH as the active center and PlcR as a chaperone protein that modulates the enzymatic activity and is required for the PlcH secretion itself (<xref ref-type="bibr" rid="B146">Stonehouse et&#xa0;al., 2002</xref>).</p>
<p>The PLC of <italic>P. aeruginosa</italic> has been shown to induce aggregation in platelets derived from platelet-rich human plasma in a concentration-dependent manner, and the enzymatic activity of PLC was required for platelet aggregation (<xref ref-type="bibr" rid="B25">Coutinho et al., 1988</xref>). Thus, PLC is heat-labile by nature (<xref ref-type="bibr" rid="B17">Berka et&#xa0;al., 1981</xref>). Some studies suggest that <italic>P. aeruginosa</italic> may have two hemolytic virulence factors that might cause paralysis, dermonecrosis, footpad swelling, vascular permeability, and death in mice (<xref ref-type="bibr" rid="B16">Berk et al., 1987</xref>).</p>
<p>Inflammation is one of the hallmark features of pulmonary infections caused by <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B157">Titball, 1998</xref>). PlcH has been shown to induce an inflammatory response in human neutrophils and polymorphonuclear cells <italic>in vitro</italic>. Treatment of neutrophils with PlcH but not PlcN increased the production of inflammation markers such as oxygen metabolites, leukotriene-B4 (LTB4), and histamine (<xref ref-type="bibr" rid="B81">K&#xf6;nig et al., 1997</xref>). Furthermore, PLC from <italic>P. aeruginosa</italic> induced an inflammatory response in mice in an enzyme activity-dependent manner. Intraperitoneal injection of PLC resulted in the induction of an inflammatory response in mice characterized by the accumulation of plasma proteins, inflammatory cells, and arachidonic acid metabolites such as LTB4, LTC4, LTD4, prostaglandin E2 (PGE2), PGF2-alpha, and thromboxane B2 (<xref ref-type="bibr" rid="B99">Meyers and Berk, 1990</xref>). While LTB4 acts as a strong stimulator for chemotactic aggregation of granulocytes, leukotriene-C4 and leukotriene-D4 cause the wheal and flare response (<xref ref-type="bibr" rid="B23">Camp et al., 1983</xref>; <xref ref-type="bibr" rid="B99">Meyers and Berk, 1990</xref>). PGE2 is known to be a powerful vasodilator believed to cause edema, erythema, and pain (<xref ref-type="bibr" rid="B175">Williams, 1979</xref>). Granstr&#xf6;m et&#xa0;al. demonstrated that the level of PLC antibodies was elevated in CF patients chronically infected with <italic>P. aeruginosa</italic>, suggesting that it helps in chronic infection (<xref ref-type="bibr" rid="B53">Granstr&#xf6;m et&#xa0;al, 1984</xref>). Several <italic>in vitro</italic> studies with human bronchial cells suggest a role for <italic>P. aeruginosa</italic> PLC in exacerbated inflammation in CF lungs, which is responsible for the poor prognosis (<xref ref-type="bibr" rid="B135">Sener et al., 1999</xref>; <xref ref-type="bibr" rid="B165">Wargo et al., 2011</xref>). There is a scientific consensus that neutrophils and pulmonary macrophages play a pivotal role in clearing pathogenic bacterial infections from the human host (<xref ref-type="bibr" rid="B135">Sener et al.,1999</xref>). Despite the abundance of neutrophils in the lung tissues, PlcHR helps <italic>P. aeruginosa</italic> survive in such detrimental conditions by suppressing respiratory neutrophil burst response (<xref ref-type="bibr" rid="B153">Terada et&#xa0;al., 1999</xref>). Other than playing a role in inducing an inflammatory response in the lungs, PLC may also contribute to lung function by destroying lung surfactants. The PlcH of <italic>P. aeruginosa</italic> has been reported to act as a destructive determinant for lung surfactant. The wild-type strain of <italic>P. aeruginosa</italic> significantly impairs the functioning of the lung surfactants, whereas the PlcHR mutant strain is remarkably less potent to cause infection (<xref ref-type="bibr" rid="B100">Montes et al., 2007</xref>). PLC helps hydrolyze PC, an abundant phospholipid in the lung surfactant, which can then be converted to glycine betaine. The accumulation of glycine betaine within the bacterial cell is thought to protect against the high osmolarity conditions found in the lung tissue, further helping bacteria to colonize the lung (<xref ref-type="bibr" rid="B137">Shortridge et al.,1992</xref>; <xref ref-type="bibr" rid="B39">Fitzsimmons et al., 2012</xref>). PLC also plays a role in biofilm formation <italic>in vitro</italic> and in animal models, further suggesting its central role in <italic>P. aeruginosa</italic>-associated morbidity and mortality in CF patients (<xref ref-type="bibr" rid="B165">Wargo et al., 2011</xref>; <xref ref-type="bibr" rid="B66">Jackson et al., 2013</xref>).</p>
<p>PlcH also contributes to <italic>P. aeruginosa</italic> virulence by stimulating the activity of the anaerobic respirational regulator Anr by releasing choline (<xref ref-type="bibr" rid="B39">Fitzsimmons et al., 2012</xref>; <xref ref-type="bibr" rid="B66">Jackson et al., 2013</xref>). Microarray analysis revealed that the nonfunctional form of PlcH had decreased levels of Anr-regulated transcripts compared with that of the wild-type strain. PlcH promotes the Anr activity, which contributes to the severity of the disease even in acute phase infection, where the oxygen level is believed to be high. Thus, Anr&#x2019;s activity promotes colonization in the host (<xref ref-type="bibr" rid="B66">Jackson et al., 2013</xref>). An increase in Anr activity activates numerous pathways involved in <italic>P. aeruginosa</italic> virulence, respiration, and biofilm formation. The <italic>anr</italic> mutant was severely impaired in its ability to colonize lung tissue and was cleared from the lung much faster compared to the wild-type strain (<xref ref-type="bibr" rid="B182">Yoon et al., 2002</xref>; <xref ref-type="bibr" rid="B177">Worlitzsch et al., 2002</xref>). These findings suggest that Anr could be a good target for developing new therapies. Other pathogens have also been reported to require Anr homologs for their virulence (<xref ref-type="bibr" rid="B10">Baltes et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B93">Mattoo et al.,2004</xref>; <xref ref-type="bibr" rid="B15">Bartolini et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B92">Marteyn et al., 2010</xref>). This way, it is also possible to devise some beneficial approaches for the treatment of other diseases.</p>
<p>Angiogenesis (formation of blood vessels) helps in the wound healing process, in which endothelial cells play a significant role. PlcHR2 has been reported as a factor that decisively induces cytotoxicity in endothelial cells, affecting angiogenesis (<xref ref-type="bibr" rid="B158">Vasil et al., 2009</xref>).</p>
</sec>
<sec id="s6_4">
<title>PLC induces hemolysis and apoptosis in host cells during <italic>Helicobacter pylori</italic> infection</title>
<p>
<italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) is a spiral-shaped, gram-negative, microaerophilic bacteria that colonizes the gastric mucosa of humans (<xref ref-type="bibr" rid="B167">Warren and Marshall, 1983</xref>; <xref ref-type="bibr" rid="B20">Brown, 2000</xref>; <xref ref-type="bibr" rid="B6">Atherton, 2006</xref>). Initially, <italic>H. pylori</italic> was classified under <italic>Campylobacter</italic>; later, in 1989, it was classified under a new genus called <italic>Helicobacter</italic> and was named <italic>Helicobacter pylori</italic> (<xref ref-type="bibr" rid="B50">Goodwin et al., 1989</xref>). It was recognized as the common causative agent of chronic gastritis and duodenal ulcers (<xref ref-type="bibr" rid="B167">Warren and Marshall, 1983</xref>; <xref ref-type="bibr" rid="B59">Hemalatha et&#xa0;al., 1991</xref>; <xref ref-type="bibr" rid="B91">Marshall and Warren et al., 1984</xref>). <italic>H. pylori</italic> adheres to the antrum&#x2019;s mucosal lining and releases urease to protect itself from the acidic environment (<xref ref-type="bibr" rid="B59">Hemalatha et&#xa0;al., 1991</xref>; <xref ref-type="bibr" rid="B106">Nakshabendi et al., 1996</xref>).</p>
<p>Several phospholipases are reported to be produced by <italic>H. pylori</italic>, including PLC, which might help the bacteria to cause ulcerogenic activity. <italic>H. pylori</italic>-mediated hemolysis might be related to their capability for the production of PLC. Studies conducted on erythrocytes derived from humans, horses, sheep, and guinea pigs showed variable degrees of hemolytic activity induced by <italic>H. pylori</italic>. It was also reported that the strains isolated from the patients with duodenal ulcers showed a higher efficiency in producing elevated levels of PLC compared to those with gastritis (<xref ref-type="bibr" rid="B172">Wetherall and Johnson et al., 1989</xref>; <xref ref-type="bibr" rid="B30">Daw et al., 1994</xref>). These observations suggest that PLC activity might be required for hemolytic activity and virulence during the pathogenicity of <italic>H. pylori</italic>.</p>
<p>Lipopolysaccharide (LPS) from <italic>H. pylori</italic> has been recognized as a potent virulence factor, causing an inflammatory response in mucosal epithelial cells, leading to gastritis and duodenal ulcers (<xref ref-type="bibr" rid="B120">Piotrowski et al., 1997</xref>; <xref ref-type="bibr" rid="B126">Rieder et al., 2003</xref>). Ghrelin, a peptide hormone, is an endogenous factor that regulates the intensity of gastric mucosal inflammation in response to <italic>H. pylori</italic> infection (<xref ref-type="bibr" rid="B79">Kojima et al., 1999</xref>; <xref ref-type="bibr" rid="B112">Osawa et al., 2005</xref>; <xref ref-type="bibr" rid="B168">Waseem et al., 2008</xref>). Both, the LPS of the bacterium and the ghrelin of the host rely on the activation of different signaling pathways involving PI-PLC in order to exert their effects the gastric mucosal inflammation <bold>(</bold>
<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>
<bold>)</bold> (<xref ref-type="bibr" rid="B138">Slomiany and Slomiany, 2015a</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>
<italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection modulates the expression of host-derived PLC-&#x3b3;2 along with several other host proteins: following the toll-like receptor 4 (TLR-4)-mediated phagocytosis by host cells, <italic>H. pylori</italic> releases the PLC in the cytosol, causing lysis of the host cells. <italic>H. pylori</italic> also induces the &#x3b3;-glutamyl transpeptidase (GGT)-mediated apoptosis of the host cell. Lipopolysaccharide (LPS) from <italic>H. pylori</italic> activates the Rac-1, which increases the expression of both host-specific PLC-&#x3b3;2 and PKC. Ghrelin further increases PKC activity and also has a modulatory effect on Rac-1 activation, which leads to inflammation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1089374-g006.tif"/>
</fig>
<p>Following toll-like receptor 4 (TLR4)-mediated phagocytosis of the bacterium, LPS from <italic>H. pylori</italic> induces the activation of Rac1 and causes gastric mucosal inflammation (<xref ref-type="bibr" rid="B80">Kong and Gee, 2008</xref>; <xref ref-type="bibr" rid="B139">Slomiany and Slomiany, 2015b</xref>). It has been reported that Rac1 activation significantly increases the activities of host-specific PLC-&#x3b3;2 and PKC and the increase in ghrelin further increases PKC activity. Slomiany et&#xa0;al. reported that activation of host PLC-&#x3b3;2 during infection with <italic>H. pylori</italic> is dependent on rac1 and is modulated by the ghrelin hormone <bold>(</bold>
<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>
<bold>)</bold> (<xref ref-type="bibr" rid="B139">Slomiany and Slomiany, 2015b</xref>).</p>
<p>Infection with <italic>H. pylori</italic> in normal human gastric mucous epithelial cells alters the intracellular Ca<sup>2+</sup> levels in PLC-dependent manner (<xref ref-type="bibr" rid="B89">Marlink et al., 2003</xref>). Infection of gastric adenocarcinoma cells with <italic>H. pylori</italic> induces apoptosis in these cells. Apoptosis was shown to be associated with an increase in intracellular Ca<sup>2+</sup>. An increase in intracellular Ca<sup>2+</sup> levels and induction of apoptosis by g-glutamyl transpeptidase (GGT) was abolished with the treatment of a PLC inhibitor (U71322) and IP3 antagonist (xestospongin). These observations suggest the requirement of PLC in <italic>H. pylori</italic>-induced apoptosis in the host cell (<xref ref-type="bibr" rid="B115">Park et al., 2014</xref>; <xref ref-type="bibr" rid="B125">Ricci et al., 2014</xref>; <xref ref-type="bibr" rid="B19">Boonyanugomol et al., 2012</xref>). Studies discussed above strongly establish PI-PLC as an important virulence factor in the pathogenesis of <italic>H. pylori</italic>.</p>
</sec>
<sec id="s6_5">
<title>PLCs in other bacterial infections</title>
<p>Different PLC isoforms are also reported to play crucial roles during several other bacterial infections, such as those caused by <italic>Legionella pneumophila</italic> (<italic>L. pneumophila</italic>), <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>), <italic>Burkholderia cepacia</italic> (<italic>B. cepacia</italic>)<italic>, and</italic> reproductive tract-associated bacterial infections. <italic>L. pneumophila</italic> is a gram-negative bacillus and the causative agent of Legionnaires. This pathogen contains three PLC (PLC-A, PLC-B, and PLC-C) genes identified in its genome. These PLCs are reported to be released inside the host cell through the secretory systems, where they manipulate host transcription, translation, phospholipid pool, and vesicle trafficking pathways. Furthermore, these PLCs also influence the host phagosome maturation and cell death pathways (<xref ref-type="bibr" rid="B61">Hiller et al., 2018</xref>). The role of PLCs in Legionnaires is not yet clearly understood and requires further investigation. <italic>S. aureus</italic> has been reported to release PI-PLC with the ability to hydrolyze the PI and glucosyl phosphatidyl inositol (GPI)-linked proteins present on the host cell surface (<xref ref-type="bibr" rid="B29">Daugherty and Low, 1993</xref>). These PI-PLCs are involved in the regulation of accessory gene regulator quorum sensing systems. The overexpression of secreted PI-PLC in <italic>S. aureus</italic> caused more severe disease, suggesting its role as a virulence factor. In line with these observations, a PLC mutant of <italic>S. aureus</italic> exhibits defective survival in human blood and neutrophils suggesting that PI-PLC might contribute to the survival of <italic>S. aureus</italic> in the host (<xref ref-type="bibr" rid="B173">White et al., 2014</xref>). Two PLC isoforms have been identified in <italic>B. cepacia</italic>, one with hemolytic (PLC-H) activity and the other without hemolytic (PLC-N) activity (<xref ref-type="bibr" rid="B170">Weingart and Hooke, 1999a</xref>; <xref ref-type="bibr" rid="B171">1999b</xref>). In <italic>Bacillus anthracis</italic>, three PLC genes have been identified, which are homologous to the PLCs from <italic>L. monocytogenes</italic>. The functions of these PLCs are not understood so far, but it is speculated that these PLCs might act as virulence factors (<xref ref-type="bibr" rid="B57">Heffernan et al., 2006</xref>; <xref ref-type="bibr" rid="B56">Heffernan et al., 2007</xref>). Several aerobic and anaerobic bacteria associated with reproductive tract infection show PLC activities, which may be linked directly or indirectly with localized cells/tissue damage and contribute to the virulence of the microorganisms (<xref ref-type="bibr" rid="B94">McGregor et al., 1991</xref>).</p>
</sec>
</sec>
<sec id="s7" sec-type="conclusion">
<title>Conclusion</title>
<p>Phospholipids have both hydrophilic and hydrophobic domains and function as the main constituent of all biological membranes. Cell surface-specific receptors receive extracellular stimuli and transmit them inside the cell in order to produce cellular effects. Thirteen different PLC isoforms with unique structures mediate the diverse signaling functions. Several extracellular signals activate the PLC enzyme, resulting in the cleavage of phospholipids into the bi-products, which in turn modulate the activities of various targets to contribute to context-specific cellular functions. PLC plays a crucial role in the pathogenesis of several bacteria and exerts a variety of effects that contribute to the disease-specific perturbation in host cells. The PLC enzyme as a virulence factor needs to be further investigated in other bacterial infections. It is important to understand how the cells discriminate between the signals and activate signal-specific PLC/PLCs whether the PLC isoforms work independently or work in a coordinated manner. Some chemical inhibitors are used to inhibit PLC&#x2019;s functions. Several studies reported that 1-[6-(17b-3-methoxyestra-1,3,5 (10)trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-dione (U71322) blocks the recruitment of PLC to the membrane and may be used as a pan PLC inhibitor. Klein et&#xa0;al. reported that the U71322 directly activates the PLC-&#x3b3;1, PLC-&#x3b2;2, and PLC-&#x3b2;3 of humans instead of inhibiting them (<xref ref-type="bibr" rid="B77">Klein et al., 2011</xref>). Some other inhibitors, like 2-nitro-4-carboxyphenyl <italic>N</italic>,<italic>N</italic>-diphenylcarbamate (NCDC) and 1-<italic>O</italic>-octadecyl-2-<italic>O</italic>-methyl-rac-glycero-3-phosphorylcholine (ET-18-OCH3), are also used to inhibit PLCs. Inhibiting PLCs with different approaches, including chemical inhibitors, may be a promising strategy to manipulate the outcome of bacterial infections.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>VS, RR, and BM did literature search and wrote the manuscript. RC, AS, and AK gave conceptual inputs and edited the manuscript as per their specializations in the field. SC conceptualized the theme of the manuscript, supervised the overall preparation of the manuscript, and contributed to the writing and editing of the final version of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>Financial support by the Core Research Grant, SERB, Department of Science and Technology, India (Grant No. CRG/2020/000520) and Seed Grant by MANIT, Bhopal (Grant No. Dean R&amp;C 19/1021 dated 14 August 2019) both sanctioned to Dr SC is acknowledged.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>VS and RR are recipients of Teaching Assistantships from MANIT, Bhopal. BM is a recipient of a CSIR-UGC Junior Research Fellowship.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdulnour</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Howrylak</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Tavares</surname> <given-names>A. H.</given-names>
</name>
<name>
<surname>Douda</surname> <given-names>D. N.</given-names>
</name>
<name>
<surname>Henkels</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>T. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury</article-title>. <source>J. Leukoc. Biol.</source> <volume>103</volume> (<issue>5</issue>), <fpage>919</fpage>&#x2013;<lpage>932</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/JLB.3A0617-252RR</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alape-Gir&#xf3;n</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Guillouard</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Naylor</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Rucavado</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Identification of residues critical for toxicity in <italic>Clostridium perfringens</italic> phospholipase C, the key toxin in gas gangrene</article-title>. <source>Eur. J. Biochem.</source> <volume>267</volume> (<issue>16</issue>), <fpage>5191</fpage>&#x2013;<lpage>5197</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01588.x</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Swigart</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cockcroft</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Regulation of inositol lipid-specific phospholipase C&#x3b4; by changes in Ca2+ ion concentrations</article-title>. <source>Biochem. J.</source> <volume>327</volume> (<issue>Pt 2</issue>), <fpage>545</fpage>&#x2013;<lpage>552</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj3270545</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Aloulou</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rahier</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Arhab</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Noiriel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abousalham</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Phospholipases: An overview</article-title>. In <person-group person-group-type="author">
<name>
<surname>Sandoval</surname> <given-names>G.</given-names>
</name>
</person-group> ed. <source>Lipases and Phospholipases: Methods and Protocols. Methods in Molecular Biology</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name>.</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Assis</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Esp&#xed;ndola</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Paula-Silva</surname> <given-names>F. W.</given-names>
</name>
<name>
<surname>Rios</surname> <given-names>W. M.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Le&#xe3;o</surname> <given-names>S. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>
<italic>Mycobacterium tuberculosis</italic> expressing phospholipase C subverts PGE2 synthesis and induces necrosis in alveolar macrophages</article-title>. <source>BMC Microbiol.</source> <volume>14</volume>, <elocation-id>128</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2180-14-128</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atherton</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The pathogenesis of <italic>Helicobacter pylori</italic>-induced gastro-duodenal diseases</article-title>. <source>Annu. Rev. Pathol.</source> <volume>1</volume>, <fpage>63</fpage>&#x2013;<lpage>96</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.pathol.1.110304.100125</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aurass</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Schlegel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Metwally</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Harding</surname> <given-names>C.R.</given-names>
</name>
<name>
<surname>Schroeder</surname> <given-names>G.N.</given-names>
</name>
<name>
<surname>Frankel</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Legionella pneumophila Dot/Icm-secreted Effector PlcC/CegC1 Together with PlcA and PlcB Promotes Virulence and Belongs to a Novel Zinc Metallophospholipase C Family Present in Bacteria and Fungi</article-title>. <source>J Biol Chem</source> <volume>288</volume> (<issue>16</issue>), <fpage>11080</fpage>&#x2013;<lpage>11092</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M112.426049</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awad</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Bryant</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Stevens</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Rood</surname> <given-names>J. I.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in <italic>Clostridium perfringens</italic>-mediated gas gangrene</article-title>. <source>Mol. Microbiol.</source> <volume>15</volume> (<issue>2</issue>), <fpage>191</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.tb02234.x</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakala N'goma</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Schu&#xe9;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Carri&#xe8;re</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Geerlof</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Canaan</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Evidence for the cytotoxic effects of <italic>Mycobacterium tuberculosis</italic> phospholipase C towards macrophages</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1801</volume> (<issue>12</issue>), <fpage>1305</fpage>&#x2013;<lpage>1313</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbalip.2010.08.007</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baltes</surname> <given-names>N.</given-names>
</name>
<name>
<surname>N'diaye</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Jacobsen</surname> <given-names>I. D.</given-names>
</name>
<name>
<surname>Maas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Buettner</surname> <given-names>F. F.</given-names>
</name>
<name>
<surname>Gerlach</surname> <given-names>G. F.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Deletion of the anaerobic regulator HlyX causes reduced colonization and persistence of <italic>Actinobacillus pleuropneumoniae</italic> in the porcine respiratory tract</article-title>. <source>Infect. Immun.</source> <volume>73</volume> (<issue>8</issue>), <fpage>4614</fpage>&#x2013;<lpage>4619</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.73.8.4614-4619.2005</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bandyopadhaya</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Das</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Chaudhuri</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Involvement of intracellular signaling cascades in inflammatory responses in human intestinal epithelial cells following <italic>Vibrio cholerae</italic> infection</article-title>. <source>Mol. Immunol.</source> <volume>46</volume> (<issue>6</issue>), <fpage>1129</fpage>&#x2013;<lpage>1139</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molimm.2008.11.003</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Filloux</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ball</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Wilderman</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A novel extracellular phospholipase C of <italic>Pseudomonas aeruginosa</italic> is required for phospholipid chemotaxis</article-title>. <source>Mol. Microbiol.</source> <volume>53</volume> (<issue>4</issue>), <fpage>1089</fpage>&#x2013;<lpage>1098</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04189.x</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett-Bee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>R. G.</given-names>
</name>
<name>
<surname>Ryley</surname> <given-names>J. F.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts</article-title>. <source>J. Gen. Microbiol.</source> <volume>131</volume> (<issue>5</issue>), <fpage>1217</fpage>&#x2013;<lpage>1221</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00221287-131-5-1217</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bar-Sagi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rotin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Batzer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mandiyan</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Schlessinger</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>SH3 domains direct cellular localization of signaling molecules</article-title>. <source>Cell</source> <volume>74</volume> (<issue>1</issue>), <fpage>83</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0092-8674(93)90296-3</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartolini</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Frigimelica</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Giovinazzi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Galli</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Shaik</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Genco</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Role of FNR and FNR-regulated, sugar fermentation genes in <italic>Neisseria meningitidis</italic> infection</article-title>. <source>Mol. Microbiol.</source> <volume>60</volume> (<issue>4</issue>), <fpage>963</fpage>&#x2013;<lpage>972</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05163.x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berk</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Coutinho</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Meyers</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>
<italic>In vivo</italic> studies with two phospholipase C fractions from <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Infect. Immun.</source> <volume>55</volume> (<issue>7</issue>), <fpage>1728</fpage>&#x2013;<lpage>1730</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.55.7.1728-1730.1987</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berka</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Gray</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Studies of phospholipase C (heat-labile hemolysin) in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Infect. Immun.</source> <volume>34</volume> (<issue>3</issue>), <fpage>1071</fpage>&#x2013;<lpage>1074</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.34.3.1071-1074.1981</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonvini</surname> <given-names>E.</given-names>
</name>
<name>
<surname>DeBell</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Ver&#xed;</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stoica</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Laborda</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>On the mechanism coupling phospholipase C&#x3b3;1 to the b- and T-cell antigen receptors</article-title>. <source>Adv. Enzyme Regul.</source> <volume>43</volume>, <fpage>245</fpage>&#x2013;<lpage>269</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0065-2571(02)00033-x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boonyanugomol</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chomvarin</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>M. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Effects of <italic>Helicobacter pylori</italic> &#x3b3;-glutamyltranspeptidase on apoptosis and inflammation in human biliary cells</article-title>. <source>Dig Dis. Sci.</source> <volume>57</volume> (<issue>10</issue>), <fpage>2615</fpage>&#x2013;<lpage>2624</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10620-012-2216-2</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>L. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>
<italic>Helicobacter pylori</italic>: epidemiology and routes of transmission</article-title>. <source>Epidemiol. Rev.</source> <volume>22</volume> (<issue>2</issue>), <fpage>283</fpage>&#x2013;<lpage>297</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/oxfordjournals.epirev.a018040</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunney</surname> <given-names>T. D.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>PLC Regulation: emerging pictures for molecular mechanisms</article-title>. <source>Trends Biochem. Sci.</source> <volume>36</volume> (<issue>2</issue>), <fpage>88</fpage>&#x2013;<lpage>96</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2010.08.003</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camilli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tilney</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Dual roles of <italic>plcA</italic> in <italic>Listeria monocytogenes</italic> pathogenesis</article-title>. <source>Mol. Microbiol.</source> <volume>8</volume> (<issue>1</issue>), <fpage>143</fpage>&#x2013;<lpage>157</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1993.tb01211.x</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camp</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Coutts</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Greaves</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>Kay</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Walport</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4</article-title>. <source>Br. J. Pharmacol.</source> <volume>80</volume> (<issue>3</issue>), <fpage>497</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1476-5381.1983.tb10721.x</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>C&#xf4;tes</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Bakala N'goma</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Dhouib</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Douchet</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Maurin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Carri&#xe8;re</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Lipolytic enzymes in <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>78</volume> (<issue>5</issue>), <fpage>741</fpage>&#x2013;<lpage>749</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00253-008-1397-2</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coutinho</surname> <given-names>I. R.</given-names>
</name>
<name>
<surname>Berk</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Mammen</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Platelet aggregation by a phospholipase C from <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Thromb. Res.</source> <volume>51</volume> (<issue>5</issue>), <fpage>495</fpage>&#x2013;<lpage>505</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0049-3848(88)90115-6</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Larman</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Hashimoto</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Swann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>F. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Sperm phospholipase Czeta from humans and cynomolgus monkeys triggers Ca2+ oscillations, activation and development of mouse oocytes</article-title>. <source>Reproduction</source> <volume>124</volume> (<issue>5</issue>), <fpage>611</fpage>&#x2013;<lpage>623</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/rep.0.1240611</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>McDade</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Tucker</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Gottfredsson</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>L. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Extracellular phospholipase activity is a virulence factor for <italic>Cryptococcus neoformans</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>166</fpage>&#x2013;<lpage>175</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02236.x</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dabiri</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Sanger</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Southwick</surname> <given-names>F. S.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>
<italic>Listeria monocytogenes</italic> moves rapidly through the host-cell cytoplasm by inducing directional actin assembly</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>87</volume> (<issue>16</issue>), <fpage>6068</fpage>&#x2013;<lpage>6072</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.87.16.6068</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daugherty</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Low</surname> <given-names>M. G.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Cloning, expression, and mutagenesis of phosphatidylinositol-specific phospholipase C from <italic>Staphylococcus aureus</italic>: A potential <italic>Staphylococcal virulence</italic> factor</article-title>. <source>Infect. Immun.</source> <volume>61</volume> (<issue>12</issue>), <fpage>5078</fpage>&#x2013;<lpage>5089</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.61.12.5078-5089.1993</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Daw</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>H. X.</given-names>
</name>
<name>
<surname>O&#x2019;Morain</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>
<italic>Helicobacter pylori</italic>: phospholipase C and Haemolysis</article-title>. In <person-group person-group-type="editor">
<name>
<surname>Gasbarrini</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Pretolani</surname> <given-names>S.</given-names>
</name>
</person-group> eds. <source>Basic and Clinical Aspects of Helicobacter pylori Infection</source>. <publisher-loc>Berlin, Heidelberg</publisher-loc>: <publisher-name>Springer</publisher-name>, <fpage>85</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-3-642-78231-2_17</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diggle</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Whiteley</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Microbe profile: <italic>Pseudomonas aeruginosa</italic>: opportunistic pathogen and lab rat</article-title>. <source>Microbiol. (Reading).</source> <volume>166</volume> (<issue>1</issue>), <fpage>30</fpage>&#x2013;<lpage>33</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.000860</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis MV</surname> <given-names>U. S.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Mutations within a highly conserved sequence present in the X region of phosphoinositide-specific phospholipase C-&#x3b4; 1</article-title>. <source>Biochem. J.</source> <volume>307</volume> (<issue>Pt 1</issue>), <fpage>69</fpage>&#x2013;<lpage>75</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj3070069</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esselmann</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>P.V.</given-names>
</name>
</person-group> (<year>1961</year>). <article-title>Lecithinase production by gram-negative bacteria</article-title>. <source>J. Bacteriol.</source> <volume>81</volume> (<issue>6</issue>), <fpage>939</fpage>&#x2013;<lpage>945</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.81.6.939-945.1961</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essen</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Perisic</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Crystal structure of a mammalian phosphoinositide-specific phospholipase C &#x3b4;</article-title>. <source>Nature</source> <volume>380</volume> (<issue>6575</issue>), <fpage>595</fpage>&#x2013;<lpage>602</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/380595a0</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essen</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Perisic</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>A ternary metal binding site in the C2 domain of phosphoinositide-specific phospholipase C-&#x3b4;1</article-title>. <source>Biochemistry</source> <volume>36</volume> (<issue>10</issue>), <fpage>2753</fpage>&#x2013;<lpage>2762</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi962466t</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exton</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Signaling through phosphatidylcholine breakdown</article-title>. <source>J. Biol. Chem.</source> <volume>265</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(19)40184-1</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falkinham</surname> <given-names>J. O.</given-names> <suffix>3rd</suffix>
</name></person-group>. (<year>1996</year>). <article-title>Epidemiology of infection by nontuberculous mycobacteria</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>9</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>215</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.9.2.177</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fanning</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Protein-protein interactions: PDZ domain networks</article-title>. <source>Curr. Biol.</source> <volume>6</volume> (<issue>11</issue>), <fpage>1385</fpage>&#x2013;<lpage>1388</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0960-9822(96)00737-3</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzsimmons</surname> <given-names>L. F.</given-names>
</name>
<name>
<surname>Hampel</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Wargo</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Cellular choline and glycine betaine pools impact osmoprotection and phospholipase C production in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>J. Bacteriol.</source> <volume>194</volume> (<issue>17</issue>), <fpage>4718</fpage>&#x2013;<lpage>4726</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00596-12</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Alape-Gir&#xf3;n</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Role of <italic>Clostridium perfringens</italic> phospholipase C in the pathogenesis of gas gangrene</article-title>. <source>Toxicon</source> <volume>42</volume> (<issue>8</issue>), <fpage>979</fpage>&#x2013;<lpage>986</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.toxicon.2003.11.013</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Alape-Gir&#xf3;n</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Catimel</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hirabayashi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nice</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>A cellular deficiency of gangliosides causes hypersensitivity to <italic>Clostridium perfringens</italic> phospholipase C</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume> (<issue>29</issue>), <fpage>26680</fpage>&#x2013;<lpage>26689</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M500278200</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Alape-Gir&#xf3;n</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Moos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Guillouard</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>). <article-title>UDP-Glucose deficiency causes hypersensitivity to the cytotoxic effect of <italic>Clostridium perfringens</italic> phospholipase C</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume> (<issue>38</issue>), <fpage>24433</fpage>&#x2013;<lpage>24438</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.273.38.24433</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Thelestam</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Alape-Gir&#xf3;n</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Effects of <italic>Clostridium perfringens</italic> phospholipase C in mammalian cells</article-title>. <source>Anaerobe</source> <volume>10</volume> (<issue>2</issue>), <fpage>115</fpage>&#x2013;<lpage>123</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.anaerobe.2003.11.002</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimoto</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Fukui</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Amanai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Isobe</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Itagaki</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Mammalian phospholipase C&#x3b6; induces oocyte activation from the sperm perinuclear matrix</article-title>. <source>Dev. Biol.</source> <volume>274</volume> (<issue>2</issue>), <fpage>370</fpage>&#x2013;<lpage>383</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ydbio.2004.07.025</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukami</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Inanobe</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kanemaru</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance</article-title>. <source>Prog. Lipid Res.</source> <volume>49</volume> (<issue>4</issue>), <fpage>429</fpage>&#x2013;<lpage>437</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.plipres.2010.06.001</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukami</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Nakao</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kataoka</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kurokawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fissore</surname> <given-names>R. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Requirement of phospholipase C&#x3b4;4 for the zona pellucida-induced acrosome reaction</article-title>. <source>Science</source> <volume>292</volume> (<issue>5518</issue>), <fpage>920</fpage>&#x2013;<lpage>923</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1059042</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukami</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kurokawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fissore</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Phospholipase C&#x3b4;4 is required for Ca2+ mobilization essential for acrosome reaction in sperm</article-title>. <source>J. Cell Biol.</source> <volume>161</volume> (<issue>1</issue>), <fpage>79</fpage>&#x2013;<lpage>88</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200210057</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gifford</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Vogel</surname> <given-names>H. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs</article-title>. <source>Biochem. J.</source> <volume>405</volume> (<issue>2</issue>), <fpage>199</fpage>&#x2013;<lpage>221</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20070255</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glomski</surname> <given-names>I. J.</given-names>
</name>
<name>
<surname>Gedde</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Tsang</surname> <given-names>A. W.</given-names>
</name>
<name>
<surname>Swanson</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The <italic>Listeria monocytogenes</italic> hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells</article-title>. <source>J. Cell Biol.</source> <volume>156</volume> (<issue>6</issue>), <fpage>1029</fpage>&#x2013;<lpage>1038</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.200201081</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodwin</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Armstrong</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Chilvers</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Sly</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>1989</year>). <article-title>Transfer of <italic>Campylobacter pylori</italic> and Campylobacter mustelae to <italic>Helicobacter</italic> gen. nov. as <italic>Helicobacter pylori</italic> comb. nov. and <italic>Helicobacter mustelae</italic> comb. nov., Respectively</article-title>. <source>Int J Syst Bacteriol</source> <volume>39</volume> (<issue>4</issue>), <fpage>397</fpage>&#x2013;<lpage>405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00207713-39-4-397</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname> <given-names>S. V.</given-names>
</name>
<name>
<surname>Parish</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Microbe profile: <italic>Mycobacterium tuberculosis</italic>: Humanity's deadly microbial foe</article-title>. <source>Microbiol. (Reading).</source> <volume>164</volume> (<issue>4</issue>), <fpage>437</fpage>&#x2013;<lpage>439</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/mic.0.000601</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gout</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Dhand</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hiles</surname> <given-names>I. D.</given-names>
</name>
<name>
<surname>Fry</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Panayotou</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Das</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>1993</year>). <article-title>The GTPase dynamin binds to and is activated by a subset of SH3 domains</article-title>. <source>Cell</source> <volume>75</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0092-8674(05)80081-9</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granstr&#xf6;m</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ericsson</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Strandvik</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Wretlind</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pavlovskis</surname> <given-names>O. R.</given-names>
</name>
<name>
<surname>Berka</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>1984</year>). <article-title>Relation between antibody response to <italic>Pseudomonas aeruginosa</italic> exoproteins and colonization/infection in patients with cystic fibrosis</article-title>. <source>Acta Paediatr. Scand.</source> <volume>73</volume> (<issue>6</issue>), <fpage>772</fpage>&#x2013;<lpage>777</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1651-2227.1984.tb17774.x</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gustafson</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tagesson</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Phospholipase C from <italic>Clostridium perfringens</italic> stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407)</article-title>. <source>Scand. J. Gastroenterol.</source> <volume>25</volume> (<issue>4</issue>), <fpage>363</fpage>&#x2013;<lpage>371</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/00365529009095500</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harlan</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Hajduk</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Fesik</surname> <given-names>S. W.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate</article-title>. <source>Nature</source> <volume>371</volume> (<issue>6493</issue>), <fpage>168</fpage>&#x2013;<lpage>170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/371168a0</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heffernan</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Thomason</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Herring-Palmer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hanna</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>
<italic>Bacillus anthracis</italic> anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>271</volume> (<issue>1</issue>), <fpage>98</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00713.x</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heffernan</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Thomason</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Herring-Palmer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shaughnessy</surname> <given-names>L.</given-names>
</name>
<name>
<surname>McDonald</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Fisher</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>
<italic>Bacillus anthracis</italic> phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax</article-title>. <source>Infect. Immun.</source> <volume>74</volume> (<issue>7</issue>), <fpage>3756</fpage>&#x2013;<lpage>3764</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00307-06</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinz</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Essen</surname> <given-names>L. O.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositide-specific phospholipases C</article-title>. <source>J. Mol. Biol.</source> <volume>275</volume> (<issue>4</issue>), <fpage>635</fpage>&#x2013;<lpage>650</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/jmbi.1997.1490</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemalatha</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Drumm</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sherman</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Adherence of <italic>Helicobacter pylori</italic> to human gastric epithelial cells in vitro</article-title>. <source>J. Med. Microbiol.</source> <volume>35</volume> (<issue>4</issue>), <fpage>197</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00222615-35-4-197</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heytens</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Parrington</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Coward</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lambrecht</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>S. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Reduced amounts and abnormal forms of phospholipase C &#x3b6; (PLC&#x3b6;) in spermatozoa from infertile men</article-title>. <source>Hum. Reprod.</source> <volume>24</volume> (<issue>10</issue>), <fpage>2417</fpage>&#x2013;<lpage>2428</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/humrep/dep207</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiller</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Michel</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Flieger</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Secreted phospholipases of the lung pathogen <italic>Legionella pneumophila</italic>
</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>308</volume> (<issue>1</issue>), <fpage>168</fpage>&#x2013;<lpage>175</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijmm.2017.10.002</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname> <given-names>J. I.</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>Y. S.</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Molecular cloning and characterization of a novel phospholipase C, PLC-&#x3b7;</article-title>. <source>Biochem. J.</source> <volume>389</volume> (<issue>Pt 1</issue>), <fpage>181</fpage>&#x2013;<lpage>186</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20041677</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichinohe</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sai</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Nakahara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Fukami</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Lack of phospholipase C-&#x3b4;1 induces skin inflammation</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>356</volume> (<issue>4</issue>), <fpage>912</fpage>&#x2013;<lpage>918</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.03.082</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iivanainen</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Martikainen</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>V&#xe4;&#xe4;n&#xe4;nen</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Katila</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Environmental factors affecting the occurrence of mycobacteria in brook sediments</article-title>. <source>J. Appl. Microbiol.</source> <volume>86</volume> (<issue>4</issue>), <fpage>673</fpage>&#x2013;<lpage>681</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2672.1999.00711.x</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irino</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nakahara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Furutani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Phospholipase C delta-type consists of three isozymes: bovine PLC&#x3b4;2 is a homologue of human/mouse PLC&#x3b4;4</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>320</volume> (<issue>2</issue>), <fpage>537</fpage>&#x2013;<lpage>543</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.05.206</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Daniels</surname> <given-names>E. F.</given-names>
</name>
<name>
<surname>Hampton</surname> <given-names>T. H.</given-names>
</name>
<name>
<surname>Hammond</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Vallet-Gely</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Anr and its activation by PlcH activity in <italic>Pseudomonas aeruginosa</italic> host colonization and virulence</article-title>. <source>J. Bacteriol.</source> <volume>195</volume> (<issue>13</issue>), <fpage>3093</fpage>&#x2013;<lpage>3104</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.02169-12</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jezyk</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Snyder</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Gershberg</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Worthylake</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Harden</surname> <given-names>T. K.</given-names>
</name>
<name>
<surname>Sondek</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Crystal structure of Rac1 bound to its effector phospholipase C-&#x3b2;2</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>13</volume> (<issue>12</issue>), <fpage>1135</fpage>&#x2013;<lpage>1140</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nsmb1175</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansen</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Gill</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria</article-title>. <source>Infect. Immun.</source> <volume>64</volume> (<issue>8</issue>), <fpage>3259</fpage>&#x2013;<lpage>3266</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.64.8.3259-3266.1996</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>K. T.</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Parrington</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Swann</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Different Ca2+-releasing abilities of sperm extracts compared with tissue extracts and phospholipase C isoforms in sea urchin egg homogenate and mouse eggs</article-title>. <source>Biochem. J.</source> <volume>346 Pt 3</volume> (<issue>Pt 3</issue>), <fpage>743</fpage>&#x2013;<lpage>749</lpage>. doi: <pub-id pub-id-type="doi">10.1042/bj3460743</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Preiter</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen</article-title>. <source>Mol. Microbiol.</source> <volume>21</volume> (<issue>6</issue>), <fpage>1219</fpage>&#x2013;<lpage>1225</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.1996.00074.x</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadamur</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ross</surname> <given-names>E. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mammalian phospholipase C</article-title>. <source>Annu. Rev. Physiol.</source> <volume>75</volume>, <fpage>127</fpage>&#x2013;<lpage>154</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183750</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname> <given-names>G. G.</given-names>
</name>
<name>
<surname>Reks</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Ondrako</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Smrcka</surname> <given-names>A. V.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Phospholipase C(&#x3f5;): a novel ras effector</article-title>. <source>EMBO J.</source> <volume>20</volume> (<issue>4</issue>), <fpage>743</fpage>&#x2013;<lpage>754</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/20.4.743</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>E. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Pathological roles of MAPK signaling pathways in human diseases</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1802</volume> (<issue>4</issue>), <fpage>396</fpage>&#x2013;<lpage>405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2009.12.009</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Zilberstein</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Margolis</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Schlessinger</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>1991</year>). <article-title>PDGF stimulation of inositol phospholipid hydrolysis requires PLC-&#x3b3; 1 phosphorylation on tyrosine residues 783 and 1254</article-title>. <source>Cell</source> <volume>65</volume> (<issue>3</issue>), <fpage>435</fpage>&#x2013;<lpage>441</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0092-8674(91)90461-7</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y. H.</given-names>
</name>
<name>
<surname>Baek</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>S. H.</given-names>
</name>
<etal/>
</person-group>. (<year>1999</year>). <article-title>Phospholipase C-&#x3b4;1 is activated by capacitative calcium entry that follows phospholipase C-&#x3b2; activation upon bradykinin stimulation</article-title>. <source>J. Biol. Chem.</source> <volume>274</volume> (<issue>37</issue>), <fpage>26127</fpage>&#x2013;<lpage>26134</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.274.37.26127</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An update on the human and animal enteric pathogen <italic>Clostridium perfringens</italic>
</article-title>. <source>Emerg. Microbes Infect.</source> <volume>7</volume> (<issue>1</issue>), <fpage>141</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41426-018-0144-8</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname> <given-names>R. R.</given-names>
</name>
<name>
<surname>Bourdon</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Costales</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>White</surname> <given-names>W. L.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>J. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Direct activation of human phospholipase C by its well known inhibitor u73122</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume> (<issue>14</issue>), <fpage>12407</fpage>&#x2013;<lpage>12416</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M110.191783</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klockgether</surname> <given-names>J.</given-names>
</name>
<name>
<surname>T&#xfc;mmler</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Recent advances in understanding <italic>Pseudomonas aeruginosa</italic> as a pathogen</article-title>. <source>F1000Res</source> <volume>6</volume>, <fpage>1261</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.12688/f1000research.10506.1</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kojima</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hosoda</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Date</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nakazato</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matsuo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kangawa</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Ghrelin is a growth-hormone-releasing acylated peptide from stomach</article-title>. <source>Nature</source> <volume>402</volume> (<issue>6762</issue>), <fpage>656</fpage>&#x2013;<lpage>660</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/45230</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>B. X.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for toll-like receptor-stimulated phagocytosis</article-title>. <source>Cell Res.</source> <volume>18</volume> (<issue>7</issue>), <fpage>745</fpage>&#x2013;<lpage>755</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cr.2008.65</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;nig</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>K&#xf6;nig</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Role of hemolytic and nonhemolytic phospholipase C from <italic>Pseudomonas aeruginosa</italic> for inflammatory mediator release from human granulocytes</article-title>. <source>Int Arch Allergy Immunol</source> <volume>112</volume> (<issue>2</issue>), <fpage>115</fpage>&#x2013;<lpage>124</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000237441</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumari</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kaur</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kaur</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Phospholipases in Bacterial Virulence and Pathogenesis</article-title>. <source>Adv. Biotechnol. Microbiol.</source> <volume>10</volume> (<issue>5</issue>), <fpage>555798</fpage>. doi: <pub-id pub-id-type="doi">10.19080/AIBM.2018.10.555798</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagercrantz</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Carson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Phelan</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Grimmond</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ros&#xe9;n</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dar&#xe9;</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>1995</year>). <article-title>Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLC&#x3b2;3)</article-title>. <source>Genomics</source> <volume>26</volume> (<issue>3</issue>), <fpage>467</fpage>&#x2013;<lpage>472</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0888-7543(95)80164-h</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Chevalier</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Cascioferro</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Frigui</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Pawlik</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Boritsch</surname> <given-names>E. C.</given-names>
</name>
<name>
<surname>Bottai</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Revisiting the role of phospholipases C in virulence and the lifecycle of <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <elocation-id>16918</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep16918</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leidich</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Koul</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jessup</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Vitullo</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>). <article-title>Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of candida albicans</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume> (<issue>40</issue>), <fpage>26078</fpage>&#x2013;<lpage>26086</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.273.40.26078</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Vasco</surname> <given-names>V. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Role of phosphoinositide-specific phospholipase C &#x3b7;2 in isolated and syndromic mental retardation</article-title>. <source>Eur. Neurol.</source> <volume>65</volume> (<issue>5</issue>), <fpage>264</fpage>&#x2013;<lpage>269</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000327307</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname> <given-names>G. F.</given-names>
</name>
<name>
<surname>Kunapuli</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Koneti Rao</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Evidence for two alternatively spliced forms of phospholipase C-&#x3b2;2 in haematopoietic cells</article-title>. <source>Br. J. Haematol.</source> <volume>110</volume> (<issue>2</issue>), <fpage>402</fpage>&#x2013;<lpage>408</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2141.2000.02201.x</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Margolis</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Zilberstein</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Franks</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Felder</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kremer</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ullrich</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>1990</year>). <article-title>Effect of phospholipase C-&#x3b3; overexpression on PDGF-induced second messengers and mitogenesis</article-title>. <source>Science</source> <volume>248</volume> (<issue>4955</issue>), <fpage>607</fpage>&#x2013;<lpage>610</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.2333512</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marlink</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Bacon</surname> <given-names>K. D.</given-names>
</name>
<name>
<surname>Sheppard</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Ashktorab</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Smoot</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Cover</surname> <given-names>T. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Effects of <italic>Helicobacter pylori</italic> on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells</article-title>. <source>Am. J. Physiol. Gastrointest Liver Physiol.</source> <volume>285</volume> (<issue>1</issue>), <fpage>G163</fpage>&#x2013;<lpage>G176</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00257.2002</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marquis</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Goldfine</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Proteolytic pathways of activation and degradation of a bacterial phospholipase C during intracellular infection by <italic>Listeria monocytogenes</italic>
</article-title>. <source>J. Cell Biol.</source> <volume>137</volume> (<issue>6</issue>), <fpage>1381</fpage>&#x2013;<lpage>1392</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.137.6.1381</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Warren</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration</article-title>. <source>Lancet</source> <volume>1</volume> (<issue>8390</issue>), <fpage>1311</fpage>&#x2013;<lpage>1315</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(84)91816-6</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marteyn</surname> <given-names>B.</given-names>
</name>
<name>
<surname>West</surname> <given-names>N. P.</given-names>
</name>
<name>
<surname>Browning</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Cole</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Shaw</surname> <given-names>J. G.</given-names>
</name>
<name>
<surname>Palm</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Modulation of <italic>Shigella</italic> virulence in response to available oxygen in vivo</article-title>. <source>Nature</source> <volume>465</volume> (<issue>7296</issue>), <fpage>355</fpage>&#x2013;<lpage>358</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature08970</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattoo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yuk</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L. L.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>J. F.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Regulation of type III secretion in <italic>Bordetella</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>52</volume> (<issue>4</issue>), <fpage>1201</fpage>&#x2013;<lpage>1214</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04053.x</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGregor</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Lawellin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Franco-Buff</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Todd</surname> <given-names>J. K.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Phospholipase C activity in microorganisms associated with reproductive tract infection</article-title>. <source>Am. J. Obstet Gynecol.</source> <volume>164</volume> (<issue>2</issue>), <fpage>682</fpage>&#x2013;<lpage>686</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0002-9378(11)80046-3</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meisenhelder</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Rhee</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Phospholipase C-&#x3b3; is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and <italic>in vitro</italic>
</article-title>. <source>Cell</source> <volume>57</volume> (<issue>7</issue>), <fpage>1109</fpage>&#x2013;<lpage>1122</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0092-8674(89)90048-2</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meldrum</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kriz</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Totty</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>P. J.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>A second gene product of the inositol-phospholipid-specific phospholipase C &#x3b4; subclass</article-title>. <source>Eur. J. Biochem.</source> <volume>196</volume> (<issue>1</issue>), <fpage>159</fpage>&#x2013;<lpage>165</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1432-1033.1991.tb15799.x</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mengaud</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Dramsi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gouin</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Vazquez-Boland</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Milon</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Cossart</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Pleiotropic control of <italic>Listeria monocytogenes</italic> virulence factors by a gene that is autoregulated</article-title>. <source>Mol. Microbiol.</source> <volume>5</volume> (<issue>9</issue>), <fpage>2273</fpage>&#x2013;<lpage>2283</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb02158.x</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mengaud</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Vicente</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Cossart</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Transcriptional mapping and nucleotide sequence of the <italic>Listeria monocytogenes</italic> hlyA region reveal structural features that may be involved in regulation</article-title>. <source>Infect. Immun.</source> <volume>57</volume> (<issue>12</issue>), <fpage>3695</fpage>&#x2013;<lpage>3701</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.57.12.3695-3701.1989</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyers</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Berk</surname> <given-names>R. S.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Characterization of phospholipase C from <italic>Pseudomonas aeruginosa</italic> as a potent inflammatory agent</article-title>. <source>Infect. Immun.</source> <volume>58</volume> (<issue>3</issue>), <fpage>659</fpage>&#x2013;<lpage>666</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.58.3.659-666.1990</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montes</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Ibarguren</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Go&#xf1;i</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Stonehouse</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Leakage-free membrane fusion induced by the hydrolytic activity of PlcHR(2), a novel phospholipase C/sphingomyelinase from <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1768</volume> (<issue>10</issue>), <fpage>2365</fpage>&#x2013;<lpage>2372</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamem.2007.04.024</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monturiol-Gross</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Flores-D&#xed;az</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pineda-Padilla</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Castro-Castro</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Alape-Giron</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>Clostridium perfringens</italic> phospholipase C induced ROS production and cytotoxicity require PKC, MEK1 and NF&#x3ba;B activation</article-title>. <source>PloS One</source> <volume>9</volume> (<issue>1</issue>), <elocation-id>e86475</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0086475</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreau</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Pieroni</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Jolivet-Reynaud</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Alouf</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Verger</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>A new kinetic approach for studying phospholipase C (<italic>Clostridium perfringens</italic> alpha toxin) activity on phospholipid monolayers</article-title>. <source>Biochemistry</source> <volume>27</volume> (<issue>7</issue>), <fpage>2319</fpage>&#x2013;<lpage>2323</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi00407a012</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagano</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Orengo</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>One fold with many functions: the evolutionary relationships between TIM barrel families based on their sequences, structures and functions</article-title>. <source>J. Mol. Biol.</source> <volume>321</volume> (<issue>5</issue>), <fpage>741</fpage>&#x2013;<lpage>765</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0022-2836(02)00649-6</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakahara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Shimozawa</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Irino</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Morita</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kudo</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>A novel Phospholipase C, PLC(&#x3b7;)2, is a neuron-specific isozyme</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume> (<issue>32</issue>), <fpage>29128</fpage>&#x2013;<lpage>29134</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M503817200</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ichinohe</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hirata</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matsuura</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Fujiwara</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Igarashi</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Phospholipase C-&#x3b4;1 is an essential molecule downstream of <italic>Foxn1</italic>, the gene responsible for the nude mutation, in normal hair development</article-title>. <source>FASEB J.</source> <volume>22</volume> (<issue>3</issue>), <fpage>841</fpage>&#x2013;<lpage>849</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.07-9239com</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakshabendi</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q. B.</given-names>
</name>
<name>
<surname>Mokhashi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gemmell</surname> <given-names>C. G.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>F. D.</given-names>
</name>
<name>
<surname>Russell</surname> <given-names>R. I.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Effect of omeprazole therapy on the survival of <italic>Helicobacter pylori</italic>, urease activity, and antral gastric histology in patients with duodenal ulcer</article-title>. <source>Helicobacter</source> <volume>1</volume> (<issue>3</issue>), <fpage>155</fpage>&#x2013;<lpage>158</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1523-5378.1996.tb00030.x</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naylor</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Eaton</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Howells</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Justin</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Moss</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>). <article-title>Structure of the key toxin in gas gangrene</article-title>. <source>Nat. Struct. Biol.</source> <volume>5</volume> (<issue>8</issue>), <fpage>738</fpage>&#x2013;<lpage>746</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/1447</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naylor</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Jepson</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Crane</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Basak</surname> <given-names>A. K.</given-names>
</name>
<etal/>
</person-group>. (<year>1999</year>). <article-title>Characterisation of the calcium-binding c-terminal domain of <italic>Clostridium perfringens</italic> alpha-toxin</article-title>. <source>J. Mol. Biol.</source> <volume>294</volume> (<issue>3</issue>), <fpage>757</fpage>&#x2013;<lpage>770</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/jmbi.1999.3279</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochsner</surname> <given-names>U. A.</given-names>
</name>
<name>
<surname>Snyder</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Effects of the twin-arginine translocase on secretion of virulence factors, stress response, and pathogenesis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>99</volume> (<issue>12</issue>), <fpage>8312</fpage>&#x2013;<lpage>8317</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.082238299</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ikari</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Matsuno</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Morimune</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nagahama</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sakurai</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Signal transduction mechanism involved in <italic>Clostridium perfringens</italic> alpha-toxin-induced superoxide anion generation in rabbit neutrophils</article-title>. <source>Infect. Immun.</source> <volume>74</volume> (<issue>5</issue>), <fpage>2876</fpage>&#x2013;<lpage>2886</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.74.5.2876-2886.2006</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oda</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Shiihara</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ohmae</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kabura</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Takagishi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>
<italic>Clostridium perfringens</italic> alpha-toxin induces the release of IL-8 through a dual pathway <italic>via</italic> TrkA in A549 cells</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1822</volume> (<issue>10</issue>), <fpage>1581</fpage>&#x2013;<lpage>1589</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2012.06.007</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osawa</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nakazato</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Date</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kita</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ohnishi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ueno</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Impaired production of gastric ghrelin in chronic gastritis associated with <italic>Helicobacter pylori</italic>
</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>90</volume> (<issue>1</issue>), <fpage>10</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2004-1330</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostroff</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Identification of a new phospholipase C activity by analysis of an insertional mutation in the hemolytic phospholipase C structural gene of <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>J. Bacteriol.</source> <volume>169</volume> (<issue>10</issue>), <fpage>4597</fpage>&#x2013;<lpage>4601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.169.10.4597-4601.1987</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otterhag</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Sommarin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pical</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>N-terminal EF-hand-like domain is required for phosphoinositide-specific phospholipase C activity in <italic>Arabidopsis thaliana</italic>
</article-title>. <source>FEBS Lett.</source> <volume>497</volume> (<issue>2-3</issue>), <fpage>165</fpage>&#x2013;<lpage>170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0014-5793(01)02453-x</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>E. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>Y. A.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>J. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>
<italic>Helicobacter pylori</italic> &#x3b3;-glutamyl transpeptidase-induced Ca(2+) release <italic>via</italic> PLC-IP3 receptors in AGS cells</article-title>. <source>Can. J. Microbiol.</source> <volume>60</volume> (<issue>12</issue>), <fpage>865</fpage>&#x2013;<lpage>868</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/cjm-2014-0464</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paroha</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chaurasiya</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Chourasia</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Phospholipase C-&#x3b3;2 promotes intracellular survival of mycobacteria</article-title>. <source>J. Cell Biochem.</source> <volume>120</volume> (<issue>4</issue>), <fpage>5062</fpage>&#x2013;<lpage>5071</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcb.27783</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paroha</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Chourasia</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Rai</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vyas</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Chaurasiya</surname> <given-names>S. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Host phospholipase C-&#x3b3;1 impairs phagocytosis and killing of mycobacteria by J774A.1 murine macrophages</article-title>. <source>Microbiol. Immunol.</source> <volume>64</volume> (<issue>10</issue>), <fpage>694</fpage>&#x2013;<lpage>702</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1348-0421.12839</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelech</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>D. E.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Signal transduction via phosphatidylcholine cycles</article-title>. <source>Trends in Biochemical Sciences</source> <volume>14</volume> (<issue>1</issue>), <fpage>28</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0968-0004(89)90086-8</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perskvist</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stendahl</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Activation of human neutrophils by <italic>Mycobacterium tuberculosis</italic> H37Ra Involves Phospholipase C&#x3b3;2, Shc Adapter Protein, and p38 mitogen-activated protein kinase</article-title>. <source>J. Immunol.</source> <volume>164</volume> (<issue>2</issue>), <fpage>959</fpage>&#x2013;<lpage>965</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.164.2.959</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piotrowski</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Piotrowski</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Skrodzka</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Slomiany</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Slomiany</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Induction of acute gastritis and epithelial apoptosis by <italic>Helicobacter pylori</italic> lipopolysaccharide</article-title>. <source>Scand. J. Gastroenterol.</source> <volume>32</volume> (<issue>3</issue>), <fpage>203</fpage>&#x2013;<lpage>211</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/00365529709000195</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Goebel</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Cossart</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Molecular determinants of <italic>Listeria monocytogenes</italic> pathogenesis</article-title>. <source>Infect. Immun.</source> <volume>60</volume> (<issue>4</issue>), <fpage>1263</fpage>&#x2013;<lpage>1267</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.60.4.1263-1267.1992</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poussin</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Leitges</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Goldfine</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The ability of <italic>Listeria monocytogenes</italic> PI-PLC to facilitate escape from the macrophage phagosome is dependent on host PKC&#x3b2;</article-title>. <source>Microb. Pathog.</source> <volume>46</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2008.09.008</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raynaud</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Guilhot</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Rauzier</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bordat</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Pelicic</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Manganelli</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>Phospholipases C are involved in the virulence of <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>45</volume> (<issue>1</issue>), <fpage>203</fpage>&#x2013;<lpage>217</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03009.x</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>K. D.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Regulation of inositol phospholipid-specific phospholipase C isozymes</article-title>. <source>J. Biol. Chem.</source> <volume>267</volume> (<issue>18</issue>), <fpage>12393</fpage>&#x2013;<lpage>12396</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)42284-3</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricci</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Giannouli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Romano</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zarrilli</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>Helicobacter pylori</italic> gamma-glutamyl transpeptidase and its pathogenic role</article-title>. <source>World J. Gastroenterol.</source> <volume>20</volume> (<issue>3</issue>), <fpage>630</fpage>&#x2013;<lpage>638</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/wjg.v20.i3.630</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rieder</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hofmann</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Hatz</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Stolte</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Enders</surname> <given-names>G. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Up-regulation of inducible nitric oxide synthase in <italic>Helicobacter pylori</italic>-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>293</volume> (<issue>6</issue>), <fpage>403</fpage>&#x2013;<lpage>412</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1078/1438-4221-00280</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roche</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Gr&#xe9;pinet</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Corde</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Kerouanton</surname> <given-names>A.</given-names>
</name>
<name>
<surname>T&#xe9;moin</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>A <italic>Listeria monocytogenes</italic> strain is still virulent despite nonfunctional major virulence genes</article-title>. <source>J. Infect. Dis.</source> <volume>200</volume> (<issue>12</issue>), <fpage>1944</fpage>&#x2013;<lpage>1948</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/648402</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rock</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Gramm</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Rothstein</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Stein</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Dick</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>1994</year>). <article-title>Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules</article-title>. <source>Cell,</source> <volume>78</volume> (<issue>5</issue>), <fpage>761</fpage>&#x2013;<lpage>771</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0092-8674(94)90462-6</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryu</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K. Y.</given-names>
</name>
<name>
<surname>Rhee</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Bovine brain cytosol contains three immunologically distinct forms of inositolphospholipid-specific phospholipase C</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>84</volume> (<issue>19</issue>), <fpage>6649</fpage>&#x2013;<lpage>6653</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.84.19.6649</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Taketomi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Murakami</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Metabolic regulation by secreted phospholipase A<sub>2</sub>
</article-title>. <source>Inflamm. Regen.</source> <volume>36</volume>, <elocation-id>7</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s41232-016-0012-7</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Larman</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Parrington</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Royse</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Blayney</surname> <given-names>L. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>PLC&#x3b6;: a sperm-specific trigger of Ca<sup>2+</sup> oscillations in eggs and embryo development</article-title>. <source>Development</source> <volume>129</volume> (<issue>15</issue>), <fpage>3533</fpage>&#x2013;<lpage>3544</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1242/dev.129.15.3533</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scandella</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Kornberg</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>A membrane-bound phospholipase A1 purified from <italic>Escherichia coli</italic>
</article-title>. <source>Biochem.</source> <volume>10</volume> (<issue>24</issue>), <fpage>4447</fpage>&#x2013;<lpage>4456</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi00800a015</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlech</surname> <given-names>W. F</given-names>
</name>
<name>
<surname>Acheson</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Foodborne Listeriosis</article-title>. <source>Clin Infect Dis</source> <volume>31</volume>(<issue>3</issue>), <fpage>770</fpage>&#x2013;<lpage>775</lpage>. doi: <pub-id pub-id-type="doi">10.1086/314008</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Sekiya</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Phospholipase C</article-title>. In <source>Encyclopedia of Biological Chemistry</source>. <publisher-name>Elsevier</publisher-name>, <fpage>467</fpage>&#x2013;<lpage>471</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-378630-2.00346-7</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sener</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Has&#xe7;elik</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Oz&#xe7;elik</surname> <given-names>U.</given-names>
</name>
<name>
<surname>G&#xfc;nalp</surname> <given-names>A.</given-names>
</name>
<name>
<surname>G&#xf6;&#xe7;men</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Neutrophil chemotaxis in acutely infected and clinically stable cystic fibrosis patients</article-title>. <source>Pediatr. Int.</source> <volume>41</volume> (<issue>5</issue>), <fpage>514</fpage>&#x2013;<lpage>518</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1442-200x.1999.01116.x</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimohama</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Homma</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Suenaga</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Fujimoto</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Taniguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Araki</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>1991</year>). <article-title>Aberrant accumulation of phospholipase C-&#x3b4; in Alzheimer brains</article-title>. <source>Am. J. Pathol.</source> <volume>139</volume> (<issue>4</issue>), <fpage>737</fpage>&#x2013;<lpage>742</lpage>.</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shortridge</surname> <given-names>V. D.</given-names>
</name>
<name>
<surname>Lazdunski</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Osmoprotectants and phosphate regulate expression of phospholipase C in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>6</volume> (<issue>7</issue>), <fpage>863</fpage>&#x2013;<lpage>871</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1992.tb01537.x</pub-id>
</citation>
</ref>
<ref id="B138">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slomiany</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Slomiany</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>a). <article-title>Role of amplification in phospholipase C&#x3b3;2 activation in modulation of gastric mucosal inflammatory responses to <italic>Helicobacter pylori</italic>: effect of ghrelin</article-title>. <source>Inflammopharmacology</source> <volume>23</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10787-014-0220-1</pub-id>
</citation>
</ref>
<ref id="B139">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slomiany</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Slomiany</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>b). <article-title>Mechanism of Rac1-induced amplification in gastric mucosal phospholipase C&#x3b3;2 activation in response to <italic>Helicobacter pylori</italic>: modulatory effect of ghrelin</article-title>. <source>Inflammopharmacology</source> <volume>23</volume> (<issue>2-3</issue>), <fpage>101</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10787-015-0231-6</pub-id>
</citation>
</ref>
<ref id="B140">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Marquis</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>N. C.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Goldfine</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>The two distinct phospholipases C of <italic>Listeria monocytogenes</italic> have overlapping roles in escape from a vacuole and cell-to-cell spread</article-title>. <source>Infect. Immun.</source> <volume>63</volume> (<issue>11</issue>), <fpage>4231</fpage>&#x2013;<lpage>4237</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.63.11.4231-4237.1995</pub-id>
</citation>
</ref>
<ref id="B141">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Zajdowicz</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>Z. R.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Role of the <italic>Pseudomonas aeruginosa</italic> PlcH tat signal peptide in protein secretion, transcription, and cross-species tat secretion system compatibility</article-title>. <source>J. Bacteriol.</source> <volume>188</volume> (<issue>5</issue>), <fpage>1762</fpage>&#x2013;<lpage>1774</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.188.5.1762-1774.2006</pub-id>
</citation>
</ref>
<ref id="B142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>C. D.</given-names>
</name>
<name>
<surname>Masago</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kariyai</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yamawaki-Kataoka</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shibatohge</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by ras</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume> (<issue>4</issue>), <fpage>2752</fpage>&#x2013;<lpage>2757</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M008324200</pub-id>
</citation>
</ref>
<ref id="B143">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Songer</surname> <given-names>J. G.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Bacterial phospholipases and their role in virulence</article-title>. <source>Trends Microbiol.</source> <volume>5</volume> (<issue>4</issue>), <fpage>156</fpage>&#x2013;<lpage>161</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0966-842X(97)01005-6</pub-id>
</citation>
</ref>
<ref id="B144">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Stahelin</surname> <given-names>R. V.</given-names>
</name>
</person-group> (<year>2016</year>). &#x201c;<article-title>Phospholipid catabolism</article-title>,&#x201d; in <source>Biochemistry of lipids, lipoproteins and membranes</source>, <edition>Sixth Edition</edition>, vol. <volume>p</volume>. (<publisher-name>Elsevier Inc</publisher-name>), <fpage>237</fpage>&#x2013;<lpage>257</lpage>.</citation>
</ref>
<ref id="B145">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Lester</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Farquharson</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes</article-title>. <source>Int. J. Mol. Med.</source> <volume>15</volume> (<issue>1</issue>), <fpage>117</fpage>&#x2013;<lpage>121</lpage>. doi: <pub-id pub-id-type="doi">10.3892/ijmm.15.1.117</pub-id>
</citation>
</ref>
<ref id="B146">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stonehouse</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Cota-Gomez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>W. E.</given-names>
</name>
<name>
<surname>Hankin</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>R. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>A novel class of microbial phosphocholine-specific phospholipases C</article-title>. <source>Mol. Microbiol.</source> <volume>46</volume> (<issue>3</issue>), <fpage>661</fpage>&#x2013;<lpage>676</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03194.x</pub-id>
</citation>
</ref>
<ref id="B147">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suh</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>J. I.</given-names>
</name>
<name>
<surname>Manzoli</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Cocco</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Peak</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Multiple roles of phosphoinositide-specific phospholipase C isozymes</article-title>. <source>BMB Rep.</source> <volume>41</volume> (<issue>6</issue>), <fpage>415</fpage>&#x2013;<lpage>434</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5483/bmbrep.2008.41.6.415</pub-id>
</citation>
</ref>
<ref id="B148">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sukumaran</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>McNamara</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Prasadarao</surname> <given-names>N. V.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>
<italic>Escherichia coli</italic> K-1 interaction with human brain micro-vascular endothelial cells triggers phospholipase C-&#x3b3;1 activation downstream of phosphatidylinositol 3-kinase</article-title>. <source>J. Biol. Chem.</source> <volume>278</volume> (<issue>46</issue>), <fpage>45753</fpage>&#x2013;<lpage>45762</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M307374200</pub-id>
</citation>
</ref>
<ref id="B149">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundararajan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Muniyan</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Latent tuberculosis: interaction of virulence factors in <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Mol. Biol. Rep.</source> <volume>48</volume> (<issue>8</issue>), <fpage>6181</fpage>&#x2013;<lpage>6196</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11033-021-06611-7</pub-id>
</citation>
</ref>
<ref id="B150">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swann</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Rogers</surname> <given-names>N. T.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>F. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>PLC&#x3b6;(zeta): a sperm protein that triggers Ca<sup>2+</sup> oscillations and egg activation in mammals</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>17</volume> (<issue>2</issue>), <fpage>264</fpage>&#x2013;<lpage>273</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcdb.2006.03.009</pub-id>
</citation>
</ref>
<ref id="B151">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanti</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Jager</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation</article-title>. <source>Curr. Opin. Pharmacol.</source> <volume>9</volume> (<issue>6</issue>), <fpage>753</fpage>&#x2013;<lpage>762</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coph.2009.07.004</pub-id>
</citation>
</ref>
<ref id="B152">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tattoli</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Sorbara</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Tooze</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Philpott</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Girardin</surname> <given-names>S. E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>
<italic>Listeria</italic> phospholipases subvert host autophagic defenses by stalling pre-autophagosomal structures</article-title>. <source>EMBO J.</source> <volume>32</volume> (<issue>23</issue>), <fpage>3066</fpage>&#x2013;<lpage>3078</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/emboj.2013.234</pub-id>
</citation>
</ref>
<ref id="B153">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terada</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Johansen</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Nowbar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> hemolytic phospholipase C suppresses neutrophil respiratory burst activity</article-title>. <source>Infect. Immun.</source> <volume>67</volume> (<issue>5</issue>), <fpage>2371</fpage>&#x2013;<lpage>2376</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.67.5.2371-2376.1999</pub-id>
</citation>
</ref>
<ref id="B154">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tidyman</surname> <given-names>W. E.</given-names>
</name>
<name>
<surname>Rauen</surname> <given-names>K. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation</article-title>. <source>Curr. Opin. Genet. Dev.</source> <volume>19</volume> (<issue>3</issue>), <fpage>230</fpage>&#x2013;<lpage>236</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gde.2009.04.001</pub-id>
</citation>
</ref>
<ref id="B155">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilney</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Portnoy</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, <italic>Listeria monocytogenes</italic>
</article-title>. <source>J. Cell Biol.</source> <volume>109</volume> (<issue>4 Pt 1</issue>), <fpage>1597</fpage>&#x2013;<lpage>1608</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.109.4.1597</pub-id>
</citation>
</ref>
<ref id="B156">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Bacterial phospholipases C</article-title>. <source>Microbiol. Rev.</source> <volume>57</volume> (<issue>2</issue>), <fpage>347</fpage>&#x2013;<lpage>366</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mr.57.2.347-366.1993</pub-id>
</citation>
</ref>
<ref id="B157">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Titball</surname> <given-names>R. W.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Bacterial phospholipases</article-title>. <source>Symposium Series (Society for Applied Microbiology)</source> <volume>27</volume>, <fpage>127S</fpage>&#x2013;<lpage>137S</lpage>.</citation>
</ref>
<ref id="B158">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasil</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Stonehouse</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Vasil</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Wadsworth</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Goldfine</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Bolcome</surname> <given-names>R. E.</given-names>
<suffix>3rd</suffix>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>A complex extracellular sphingomyelinase of <italic>Pseudomonas aeruginosa</italic> inhibits angiogenesis by selective cytotoxicity to endothelial cells</article-title>. <source>PloS Pathog.</source> <volume>5</volume> (<issue>5</issue>), <elocation-id>e1000420</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1000420</pub-id>
</citation>
</ref>
<ref id="B159">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasquez</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Mouchlis</surname> <given-names>V. D.</given-names>
</name>
<name>
<surname>Dennis</surname> <given-names>E. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Review of four major distinct types of human phospholipase A<sub>2</sub>
</article-title>. <source>Adv. Biol. Regul.</source> <volume>67</volume>, <fpage>212</fpage>&#x2013;<lpage>218</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbior.2017.10.009</pub-id>
</citation>
</ref>
<ref id="B160">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verkleij</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Zwaal</surname> <given-names>R. F.</given-names>
</name>
<name>
<surname>Roelofsen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Comfurius</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kastelijn</surname> <given-names>D.</given-names>
</name>
<name>
<surname>van Deenen</surname> <given-names>L. L.</given-names>
</name>
</person-group> (<year>1973</year>). <article-title>The asymmetric distribution of phospholipids in the human red cell membrane. a combined study using phospholipases and freeze-etch electron microscopy</article-title>. <source>Biochim. Biophys. Acta</source> <volume>323</volume> (<issue>2</issue>), <fpage>178</fpage>&#x2013;<lpage>193</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0005-2736(73)90143-0</pub-id>
</citation>
</ref>
<ref id="B161">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Vines</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Phospholipase C</article-title>. In <person-group person-group-type="editor">
<name>
<surname>Islam</surname> <given-names>S.</given-names>
</name>
</person-group> ed. <source>Calcium Signaling</source>. Advances in Experimental Medicine and Biology. <publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer Netherlands</publisher-name>, <fpage>235</fpage>&#x2013;<lpage>254</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-94-007-2888-2_10</pub-id>
</citation>
</ref>
<ref id="B162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahl</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Daniel</surname> <given-names>T. O.</given-names>
</name>
<name>
<surname>Carpenter</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of a-431 cells</article-title>. <source>Science</source> <volume>241</volume> (<issue>4868</issue>), <fpage>968</fpage>&#x2013;<lpage>970</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.2457254</pub-id>
</citation>
</ref>
<ref id="B163">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldo</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Ricks</surname> <given-names>T. K.</given-names>
</name>
<name>
<surname>Hicks</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Cheever</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Kawano</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Tsuboi</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Kinetic scaffolding mediated by a phospholipase C-&#x3b2; and Gq Signaling Complex</article-title>. <source>Science</source> <volume>330</volume> (<issue>6006</issue>), <fpage>974</fpage>&#x2013;<lpage>980</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1193438</pub-id>
</citation>
</ref>
<ref id="B164">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>C. K.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Extensions of PDZ domains as important structural and functional elements</article-title>. <source>Protein Cell.</source> <volume>1</volume> (<issue>8</issue>), <fpage>737</fpage>&#x2013;<lpage>751</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13238-010-0099-6</pub-id>
</citation>
</ref>
<ref id="B165">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wargo</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Rajamani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Allard</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Lundblad</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>G. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Hemolytic phospholipase C inhibition protects lung function during <italic>Pseudomonas aeruginosa</italic> infection</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>184</volume> (<issue>3</issue>), <fpage>345</fpage>&#x2013;<lpage>354</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201103-0374OC</pub-id>
</citation>
</ref>
<ref id="B166">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wargo</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Gross</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Whittaker</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Hogan</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>GbdR regulates <italic>Pseudomonas aeruginosa</italic> plcH and pchP transcription in response to choline catabolites</article-title>. <source>Infect. Immun.</source> <volume>77</volume> (<issue>3</issue>), <fpage>1103</fpage>&#x2013;<lpage>1111</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01008-08</pub-id>
</citation>
</ref>
<ref id="B167">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Marshall</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Unidentified curved bacilli on gastric epithelium in active chronic gastritis</article-title>. <source>Lancet</source> <volume>1</volume> (<issue>8336</issue>), <fpage>1273</fpage>&#x2013;<lpage>1275</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(83)92719-8</pub-id>
</citation>
</ref>
<ref id="B168">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waseem</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Duxbury</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ashley</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>M. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways</article-title>. <source>Surgery</source> <volume>143</volume> (<issue>3</issue>), <fpage>334</fpage>&#x2013;<lpage>342</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.surg.2007.09.039</pub-id>
</citation>
</ref>
<ref id="B169">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wayne</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Sohaskey</surname> <given-names>C. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Nonreplicating persistence of <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>55</volume>, <fpage>139</fpage>&#x2013;<lpage>163</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.micro.55.1.139</pub-id>
</citation>
</ref>
<ref id="B170">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weingart</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Hooke</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>1999</year>a). <article-title>A nonhemolytic phospholipase C from <italic>Burkholderia cepacia</italic>
</article-title>. <source>Curr. Microbiol.</source> <volume>38</volume> (<issue>4</issue>), <fpage>233</fpage>&#x2013;<lpage>238</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/pl00006793</pub-id>
</citation>
</ref>
<ref id="B171">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weingart</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Hooke</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>1999</year>b). <article-title>Regulation of expression of the nonhemolytic phospholipase C of <italic>Burkholderia cepacia</italic>
</article-title>. <source>Curr. Microbiol.</source> <volume>39</volume> (<issue>6</issue>), <fpage>336</fpage>&#x2013;<lpage>0341</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s002849900468</pub-id>
</citation>
</ref>
<ref id="B172">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wetherall</surname> <given-names>B. L.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Haemolytic activity of <italic>Campylobacter pylori</italic>
</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>8</volume> (<issue>8</issue>), <fpage>706</fpage>&#x2013;<lpage>710</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF01963756</pub-id>
</citation>
</ref>
<ref id="B173">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Boyd</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Horswill</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Nauseef</surname> <given-names>W. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Phosphatidylinositol-specific phospholipase C contributes to survival of <italic>Staphylococcus aureus</italic> USA300 in human blood and neutrophils</article-title>. <source>Infect. Immun.</source> <volume>82</volume> (<issue>4</issue>), <fpage>1559</fpage>&#x2013;<lpage>1571</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01168-13</pub-id>
</citation>
</ref>
<ref id="B174">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>R. L.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Mammalian phosphoinositide-specific phospholipase C</article-title>. <source>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</source> <volume>1441</volume> (<issue>2-3</issue>), <fpage>255</fpage>&#x2013;<lpage>267</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1388-1981(99)00150-X</pub-id>
</citation>
</ref>
<ref id="B175">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation</article-title>. <source>Br. J. Pharmacol.</source> <volume>65</volume> (<issue>3</issue>), <fpage>517</fpage>&#x2013;<lpage>524</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1476-5381.1979.tb07860.x</pub-id>
</citation>
</ref>
<ref id="B176">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilton</surname> <given-names>D.C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Phospholipases</article-title>. In <person-group person-group-type="editor">
<name>
<surname>Vance</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Vance</surname> <given-names>J. E.</given-names>
</name>
</person-group> eds. <source>Biochemistry of Lipids, Lipoproteins and Membranes</source>. <publisher-name>Elsevier</publisher-name>.</citation>
</ref>
<ref id="B177">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Worlitzsch</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Tarran</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ulrich</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schwab</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Cekici</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>K. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>Effects of reduced mucus oxygen concentration in airway pseudomonas infections of cystic fibrosis patients</article-title>. <source>J. Clin. Invest.</source> <volume>109</volume> (<issue>3</issue>), <fpage>317</fpage>&#x2013;<lpage>325</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI13870</pub-id>
</citation>
</ref>
<ref id="B178">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wortzel</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Seger</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The ERK cascade: Distinct functions within various subcellular organelles</article-title>. <source>Genes Cancer</source> <volume>2</volume> (<issue>3</issue>), <fpage>195</fpage>&#x2013;<lpage>209</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1947601911407328</pub-id>
</citation>
</ref>
<ref id="B179">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). &#x201c;<article-title>
<italic>Pseudomonas aeruginosa</italic>
</article-title>,&#x201d; in <source>Molecular medical microbiology</source>, <edition>2nd ed.</edition> (<publisher-name>Elsevier Ltd</publisher-name>), <fpage>753</fpage>&#x2013;<lpage>767</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-397169-2.00041-X</pub-id>
</citation>
</ref>
<ref id="B180">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Schorey</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase</article-title>. <source>J. Immunol.</source> <volume>176</volume> (<issue>9</issue>), <fpage>5494</fpage>&#x2013;<lpage>5503</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.176.9.5494</pub-id>
</citation>
</ref>
<ref id="B181">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yagisawa</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tanase</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nojima</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Phospholipase C-&#x3b4; gene of the spontaneously hypertensive rat harbors point mutations causing amino acid substitutions in a catalytic domain</article-title>. <source>J. Hypertens.</source> <volume>9</volume> (<issue>11</issue>), <fpage>997</fpage>&#x2013;<lpage>1004</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00004872-199111000-00004</pub-id>
</citation>
</ref>
<ref id="B182">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Hennigan</surname> <given-names>R. F.</given-names>
</name>
<name>
<surname>Hilliard</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Ochsner</surname> <given-names>U. A.</given-names>
</name>
<name>
<surname>Parvatiyar</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kamani</surname> <given-names>M. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis</article-title>. <source>Dev. Cell.</source> <volume>3</volume> (<issue>4</issue>), <fpage>593</fpage>&#x2013;<lpage>603</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1534-5807(02)00295-2</pub-id>
</citation>
</ref>
<ref id="B183">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Jellerette</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Salicioni</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Yoo</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Coward</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Human sperm devoid of PLC, zeta 1 fail to induce Ca<sup>2+</sup> release and are unable to initiate the first step of embryo development</article-title>. <source>J. Clin. Invest.</source> <volume>118</volume> (<issue>11</issue>), <fpage>3671</fpage>&#x2013;<lpage>3681</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI36942</pub-id>
</citation>
</ref>
<ref id="B184">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wing</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Sondek</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Harden</surname> <given-names>T. K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Molecular cloning and characterization of PLC-&#x3b7;2</article-title>. <source>Biochem. J.</source> <volume>391</volume> (<issue>Pt 3</issue>), <fpage>667</fpage>&#x2013;<lpage>676</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20050839</pub-id>
</citation>
</ref>
<ref id="B185">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Privratsky</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Transient receptor potential channel 1 deficiency impairs host defense and proinflammatory responses to bacterial infection by regulating protein kinase C&#x3b1; signaling</article-title>. <source>Mol. Cell Biol.</source> <volume>35</volume> (<issue>16</issue>), <fpage>2729</fpage>&#x2013;<lpage>2739</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.00256-15</pub-id>
</citation>
</ref>
</ref-list>
<glossary>
<title>Glossary</title>
<table-wrap position="anchor">
<table frame="hsides">
<tbody>
<tr>
<td valign="top" align="left">Anr</td>
<td valign="top" align="left">anaerobic respiration</td>
</tr>
<tr>
<td valign="top" align="left">Asn<sup>294</sup>
</td>
<td valign="top" align="left">asparagine residue at 294<sup>th</sup> position</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>B. cepacia</italic>
</td>
<td valign="top" align="left">
<italic>Burkholderia cepacia</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>C. perfringens</italic>
</td>
<td valign="top" align="left">
<italic>Clostridium perfringens</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">Ca<sup>2+</sup>
</td>
<td valign="top" align="left">calcium ion</td>
</tr>
<tr>
<td valign="top" align="left">CF</td>
<td valign="top" align="left">cystic fibrosis</td>
</tr>
<tr>
<td valign="top" align="left">COX-2</td>
<td valign="top" align="left">cyclooxygenase-2</td>
</tr>
<tr>
<td valign="top" align="left">DAG</td>
<td valign="top" align="left">di-acyl-glycerol</td>
</tr>
<tr>
<td valign="top" align="left">EP-2</td>
<td valign="top" align="left">prostaglandin E2 receptor-2</td>
</tr>
<tr>
<td valign="top" align="left">EP-4</td>
<td valign="top" align="left">prostaglandin E2 receptor-4</td>
</tr>
<tr>
<td valign="top" align="left">ET-18-OCH3</td>
<td valign="top" align="left">1-<italic>O</italic>-octadecyl-2-<italic>O</italic>-methyl-rac-glycero-3-phosphorylcholine</td>
</tr>
<tr>
<td valign="top" align="left">GEF</td>
<td valign="top" align="left">guanine exchange factor</td>
</tr>
<tr>
<td valign="top" align="left">GGT</td>
<td valign="top" align="left">&#x3bb;-glutamyl transpeptidase</td>
</tr>
<tr>
<td valign="top" align="left">GPI</td>
<td valign="top" align="left">glucosyl phosphatidyl inositol</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>H. pylori</italic>
</td>
<td valign="top" align="left">
<italic>Helicobacter pylori</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">His<sup>311</sup>
</td>
<td valign="top" align="left">histidine residue at 311th position</td>
</tr>
<tr>
<td valign="top" align="left">His<sup>356</sup>
</td>
<td valign="top" align="left">histidine residue at 356th position</td>
</tr>
<tr>
<td valign="top" align="left">JNK</td>
<td valign="top" align="left">Jun N-terminal protein kinase</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>L. monocytogenes</italic>
</td>
<td valign="top" align="left">
<italic>Listeria monocytogenes</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>L. pneumophila</italic>
</td>
<td valign="top" align="left">
<italic>Legionella pneumophila</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">LPS</td>
<td valign="top" align="left">lipopolysaccharide</td>
</tr>
<tr>
<td valign="top" align="left">LTB4</td>
<td valign="top" align="left">leukotrine B4</td>
</tr>
<tr>
<td valign="top" align="left">MAPK</td>
<td valign="top" align="left">mitogen activated protein kinases</td>
</tr>
<tr>
<td valign="top" align="left">MS</td>
<td valign="top" align="left">
<italic>Mycobacterium smegmatis</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">Mtb</td>
<td valign="top" align="left">
<italic>Mycobacterium tuberculosis</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">NCDC</td>
<td valign="top" align="left">
<italic>N</italic>,<italic>N</italic>-diphenylcarbamate</td>
</tr>
<tr>
<td valign="top" align="left">NF&#x3ba;B</td>
<td valign="top" align="left">nuclear factor-&#x3ba;B</td>
</tr>
<tr>
<td valign="top" align="left">NO</td>
<td valign="top" align="left">nitric oxide</td>
</tr>
<tr>
<td valign="top" align="left">O<sub>2</sub>
</td>
<td valign="top" align="left">superoxide anions</td>
</tr>
<tr>
<td valign="top" align="left">IP3</td>
<td valign="top" align="left">inositol triphosphate</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>P. aeruginosa</italic>
</td>
<td valign="top" align="left">
<italic>Pseudomonas aeruginosa</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">PC</td>
<td valign="top" align="left">phosphatidylcholine</td>
</tr>
<tr>
<td valign="top" align="left">PDK 1</td>
<td valign="top" align="left">3-phosphoinositide-dependent protein kinase 1</td>
</tr>
<tr>
<td valign="top" align="left">PI</td>
<td valign="top" align="left">phosphatidylinositol</td>
</tr>
<tr>
<td valign="top" align="left">PIP2</td>
<td valign="top" align="left">phosphatidylinositol 4,5 bisphosphate</td>
</tr>
<tr>
<td valign="top" align="left">PKC</td>
<td valign="top" align="left">protein kinase C</td>
</tr>
<tr>
<td valign="top" align="left">PL</td>
<td valign="top" align="left">phospholipase</td>
</tr>
<tr>
<td valign="top" align="left">PLA</td>
<td valign="top" align="left">phospholipase A</td>
</tr>
<tr>
<td valign="top" align="left">PLB</td>
<td valign="top" align="left">phospholipase B</td>
</tr>
<tr>
<td valign="top" align="left">PLC</td>
<td valign="top" align="left">phospholipase C</td>
</tr>
<tr>
<td valign="top" align="left">PLD</td>
<td valign="top" align="left">phospholipase D</td>
</tr>
<tr>
<td valign="top" align="left">PH domain</td>
<td valign="top" align="left">Pleckstrin homology domain</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>S. aureus</italic>
</td>
<td valign="top" align="left">
<italic>Staphylococcus aureus</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">TNF-&#x3b1;</td>
<td valign="top" align="left">tumor necrosis factor-&#x3b1;</td>
</tr>
<tr>
<td valign="top" align="left">TLR</td>
<td valign="top" align="left">Toll-like receptor</td>
</tr>
<tr>
<td valign="top" align="left">U71322</td>
<td valign="top" align="left">1-[6-((17&#x3b2;-3-methoxyestra-1,3,5(10)trien-17 yl)amino)hexyl]-1H-pyrrole-2,5-dione</td>
</tr>
<tr>
<td valign="top" align="left">Rac 1</td>
<td valign="top" align="left">Ras-related C3 botulinum toxin substrate 1</td>
</tr>
<tr>
<td valign="top" align="left">ROI</td>
<td valign="top" align="left">reactive oxygen intermediates</td>
</tr>
<tr>
<td valign="top" align="left">SH2 domain</td>
<td valign="top" align="left">Src homology 2 domain</td>
</tr>
<tr>
<td valign="top" align="left">SH3 domain</td>
<td valign="top" align="left">Src homology 3 domain</td>
</tr>
<tr>
<td valign="top" align="left">TAT</td>
<td valign="top" align="left">Twin arginine translocase</td>
</tr>
<tr>
<td valign="top" align="left">TB</td>
<td valign="top" align="left">tuberculosis</td>
</tr>
<tr>
<td valign="top" align="left">TIM</td>
<td valign="top" align="left">triose phosphate isomerase</td>
</tr>
<tr>
<td valign="top" align="left">TrkA</td>
<td valign="top" align="left">tropomyosin receptor kinase A</td>
</tr>
<tr>
<td valign="top" align="left">TRPC-1</td>
<td valign="top" align="left">transient receptor potential channel 1</td>
</tr>
<tr>
<td valign="top" align="left">Tyr<sup>62</sup>
</td>
<td valign="top" align="left">tyrosine residue at 62nd position</td>
</tr>
<tr>
<td valign="top" align="left">WT</td>
<td valign="top" align="left">wild type</td>
</tr>
<tr>
<td valign="top" align="left">Zn<sup>2+</sup>
</td>
<td valign="top" align="left">zinc ion</td>
</tr>
</tbody>
</table>
</table-wrap>
</glossary>
</back>
</article>